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Abstract
Colorectal cancer (CRC) is the third leading cause of cancer incidence and mortality in the 
United States, with an estimated 140,000 new cases and 51,000 deaths expected in 2018. Like 
most cancers, the burden of CRC is unequally distributed among population groups. The current 
dissertation included two studies filling gaps in knowledge about CRC disparities. Study 1 
characterized the relationship between educational attainment and CRC mortality by 
race/ethnicity. Six years of CRC mortality data (2012-2017) from the diverse state of California, 
with 30,180 deaths were analyzed. Sex-specific mortality rate ratios (MRR) stratified by 
race/ethnicity as well as by educational level were computed using negative binomial regression 
models. Among Non-Hispanic White (NHW), Non-Hispanic Black (NHB), Hispanic, and 
Asian/Pacific Islander (API) men and women, those with only a high school education had 
between 8%-45% higher CRC mortality than those with at least an Associate’s Degree. Mortality 
advantages for APIs and Hispanics, typically reported in the literature, were limited to the lower 
levels of education. At the highest educational level, Filipino men had 17% (MRR:1.17; 95% CI: 
1.01-1.37) higher mortality than NHWs. Study 2, using 12,413 CRC cases in Nevada from 2003-
2013, calculated five-year cause-specific, age-adjusted, overall survival from CRC, stratified by 
sex, race/ethnicity, and region of Nevada using the life tables method. Cox Proportional Hazards 
regression modelling computed determinants of CRC survival. Five-year CRC survival was low: 
56.0% (95% CI: 54.6-57.5) among males and 59.5% (95% CI: 58.0-61.1) among females; 
significantly lower than national 5-year survival. No survival disparities were found between 
NHW and NHB populations in Nevada. Low survival was driven by populous Southern Nevada: 
After adjustment for all covariates, Southern Nevadans were at 17% higher risk of death than 
their counterparts in Northwestern Nevada (HR: 1.17; 95% CI: 1.08-1.27). CRC screening, 
iv 
comparatively low among Nevadans, immigrants, minorities, and people with lower levels of 
education, is one modifiable factor that has the potential to improve CRC outcomes. 
Collaboratively, all stakeholders must aggressively approach any opportunities to improve 
primary prevention of CRC as well as to maximize the CRC survival potential, thus, reducing the 
number of deaths from this potentially preventable cancer.   
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Chapter 1. Introduction 
1.1 Colorectal Cancer 
Colorectal cancer (CRC) is a type of solid tumor that originates in either the colon (large 
intestine) or the rectum. Of all CRC cases, 41% are proximal, or right-sided tumors, which occur 
either in the ascending or transverse colon. 22% are distal, or left-sided, tumors, occurring in the 
descending colon or sigmoid, and 28% are rectal. Tumor staging, and concurrently disease 
prognosis, for CRC largely depends upon the extent of spread from the mucosa, submucosa, 
thick muscle layers, outermost layers, lymph nodes, nearby organs, distant organs, and 
abdominal cavity lining (American Cancer Society, 2017). 
Clinical staging for CRC, using the Cancer Staging Manual, developed and updated by 
the American Joint Committee on Cancer (AJCC), ranges from I-IV, and uses the TNM system, 
assessing the extent and size of the tumor (T), the spread to nearby lymph nodes (N), and the 
spread, or metastases, to distant sites (M) (Amin et al., 2017). SEER Summary staging, a 
simplified 3-category system often used in population-based epidemiological studies, designates 
tumors as either local, regional, or distant (Fritz, Hurlbut, Young, & Roffers, 2001).  
Survival from CRC is highly dependent upon stage at diagnosis. Patients with local 
tumors, accounting for 38% of all colon cases, have a 5-year relative survival proportion of 91%; 
for regional colon tumors (36%), survival is 72%, and for distant tumors, accounting for 22% of 
all colon cancer cases, survival is only 13%. Rectal cancer survival is similar to CRC at each 
stage, with 43%, 33%, and 18% 5-year relative survival for local, regional, and distant stages, 
respectively. Notably, across the US, rectal cancer has a more favorable stage distribution than 
colon (Siegel et al., 2017). 
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Treatment for CRC varies by stage at diagnosis. Most patients with AJCC stage I, II, and 
III colon tumors have wide surgical resection and anastomosis as treatment. Some stage II as 
well as most stage III patients also have adjuvant chemotherapy. For rectal cancer at stage I, 
local excision or resection is common, with or without chemotherapy and/or radiation. 
Neoadjuvant chemotherapy is used for stage II and III rectal tumors before surgery; radiation is 
used after. Metastatic tumors, stage IV, are generally treated with chemotherapy as well as newer 
targeted therapies (Miller et al., 2016).  
 The vast majority (96%) of CRC are adenocarcinomas; some rare types include 
carcinoids, gastrointestinal stromal tumors, lymphomas and sarcomas. Less than 5% of CRC are 
associated with DNA mutations, including Lynch syndrome, alternatively called hereditary non-
polyposis colon cancer, which accounts for 2-4% of all CRC tumors, and familial adenomatous 
polyposis, accounting for less than 1% (American Cancer Society, 2017). 
1.2 Population-Based Cancer Indicators and Disparities 
One of the fundamental requirements of approaching cancer prevention and control is 
having adequate measures of the three major cancer outcomes, incidence, survival, and 
mortality; descriptive cancer epidemiology serves this purpose (Lau, Duggal, & Ehrhardt, 2018). 
Incidence is a measure of new cases in the population, reflecting the distribution of risk factors, 
and for CRC specifically, the uptake of screening which may prevent development of a cancer by 
the removal of polyps (Ellis et al., 2014). Survival after a CRC diagnosis reflects tumor, patient, 
social, and clinical characteristics, including access and availability to quality health care, 
amenability to treatment, and stage at diagnosis, often improved with timely CRC screening. 
Mortality, captured by deaths per population, is a combined measure of past trends in survival 
and incidence (Ellis et al., 2014). Health disparities occur when there are inequalities in any of 
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these three major indicators based on sex, race/ethnicity, education level, geography, etc. that are 
potentially avoidable. In other words, while CRC is not completely preventable or curable, 
historical discrimination and/or systemic practices result in disparities. Proper characterization of 
these disparities is fundamental to any plan to reduce or eliminate them.  
1.3 Epidemiology of Colorectal Cancer in the United States 
Colorectal cancer is the third leading cause of cancer incidence and mortality among both 
men and women in the United States, despite decades of decreasing trends, with an estimated 
140,000 new cases and 51,000 deaths expected in 2018 (Siegel et al., 2017; Siegel, Miller, & 
Jemal, 2018). It currently accounts for 9% of all cancer cases and 7% of all cancer deaths among 
males, and 8% of cases and deaths for females. The lifetime probability of developing CRC in 
the US is 1 in 22 for women and 1 in 24 for men (American Cancer Society, 2017). Men have a 
30% higher incidence of CRC than women and a 40% higher mortality. Notably, on a national 
level, no significant differences by sex exist for CRC survival (Siegel et al., 2017). Due to 
improvements in screening and treatment, the 5-year relative survival from CRC for all stages 
combined has increased from 50% in 1975 to 66% in 2012 (Jemal, Ward, Johnson, Cronin, Ma, 
Ryerson, Mariotto, Lake, Wilson, & Sherman, 2017). As of 2016, an estimated 1.4 million 
people were alive in the US who had been diagnosed with CRC. 85% of survivors were ages 60 
and above; the median age at diagnosis for CRC is 66 for males and 70 for females (Miller et al., 
2016).  
While the majority of cases occur among those ages 65 and older, CRC also impacts 
younger populations, with 45% and 39% of cases occurring among males and females that are 
younger than 65, respectively. Moreover, in contrast with the declining rates among those older 
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than 50, mortality among younger populations (less than 50 years old) has increased by 13% 
since 2000; CRC incidence in this age group has increased 22% (Siegel et al., 2017).  
While rate declines have been seen in recent decades, partially attributable to 
improvements in treatments and partially to the increased reach of CRC screening on a 
population basis, improvements are not distributed evenly among population groups (Siegel et 
al., 2017). In aggregate, non-Hispanic blacks (NHB) and American-Indian/Alaskan Natives 
(AI/AN) suffer disproportionate CRC incidence and mortality burden compared to non-Hispanic 
whites (NHWs). Hispanics and Asian/Pacific Islanders (API) in aggregate fare better (Siegel, 
Desantis, & Jemal, 2014). Moreover, survival is lowest for NHBs (Doubeni et al., 2007; Siegel et 
al., 2017). Additional disparities are evident where racial/ethnic groups are analyzed separately 
by distinct population. For example, although Hispanics in aggregate have lower mortality, 
Puerto Ricans and Cubans have been shown to have equal or slightly higher mortality than 
NHWs (Pinheiro, Callahan, Siegel, et al., 2017). Similarly, when disaggregated by birthplace, 
US-born Hispanic males compared to NHWS have higher CRC mortality, and even more so in 
comparison to their foreign-born Hispanic counterparts (Pinheiro, Callahan, Gomez, et al., 
2017). Likewise, among NHBs there are intra-racial and birthplace differences, with highest 
CRC mortality seen for US-born blacks but a relatively low burden for Afro-Caribbeans 
(Pinheiro, Callahan, Boscoe, et al., 2018; Pinheiro et al., 2016). Asians, who, like Hispanics, 
have lower incidence rates in aggregate, have considerable heterogeneity in CRC incidence: 
Japanese have incidence rates higher than NHWS; Chinese and South Asians have lower rates, 
and there is no significant difference in incidence rates between NHWs and Filipinos, Koreans, 
and Vietnamese groups (Jin, Pinheiro, Xu, & Amei, 2016). Moreover, survival among Filipino 
males has been shown to be lower than NHWs in California; while Japanese men and women 
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have higher survival (Lin et al., 2002). The absolute highest CRC burden for any US 
racial/ethnic group is observed among the native populations of Alaska (Siegel et al., 2014; 
Siegel et al., 2017).     
1.4 Risk Factors for Colorectal Cancer 
Like most cancers, multiple factors increase and decrease the risk of developing CRC. 
Demographic factors including increasing age, male sex, and race/ethnicity, as described above, 
are known risk factors. Additionally, many researchers have examined the association between 
various factors and CRC incidence. Meta-analyses provide summary results of the known 
associations, as outlined in Table 1 and Table 2 below (Chan & Giovannucci, 2010; Cho et al., 
2004; Huxley et al., 2009; Johnson et al., 2013).  
Table 1: Known risk factors for CRC, with associated relative risks (RR) from meta-
analyses. 
Risk Factors for CRC RR 
Inflammatory Bowel Disease 2.93 
Family History 1.80 
Obesity/BMI 1.19  
Alcohol 1.56  
Diabetes (colon only) 1.25 
Red meat 1.21 
Processed Meat 1.19 
Smoking 1.16 
 
Table 2: Known protective factors for CRC, with associated relative risks (RR) from meta-
analyses. 
Protective Factors RR 
Physical Activity 0.81 
Aspirin/NSAIDS* 0.60 
Fruit Consumption 0.84 
Vegetable Consumption 0.86 
Dietary Calcium 0.83 
*USPSTF: harm outweighs benefit in normal risk adults 
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1.5 Colorectal Cancer Screening 
Most of the temporal gains seen in CRC outcomes have been attributed to the American 
Cancer Society’s policy recommendations in 1980 for CRC screening among healthy non-
symptomatic adults (Saldana-Ruiz, Clouston, Rubin, Colen, & Link, 2013). These guidelines 
have been revised and updated periodically; the latest versions from the American Cancer 
Society and the United States Preventative Services Task Force (USPSTF) recommend routine 
screening for normal-risk adults of ages 50-75. Screening options vary from direct visualization 
tests, such as colonoscopy or flexible sigmoidoscopy, every 5-10 years, to annual stool-based 
tests (Smith et al., 2017; U.S. Preventive Services Task Force, 2008). The evidence of 
effectiveness is compelling enough to warrant an A grade from the USPSTF, suggesting high 
certainty that the net benefit is substantial (U.S. Preventive Services Task Force, 2008). In cohort 
studies, colonoscopy screening has been shown to reduce CRC incidence by 40% and CRC 
mortality by 50%, both by preventing the disease through the detection and removal of pre-
cancerous polyps, which can slowly progress to cancer, as well as the detection of CRC at earlier 
stages, which have a more favorable prognosis (American Cancer Society, 2017).    
Despite compelling evidence of the benefits, almost one-third of eligible US adults in 
2010 had never had any type of CRC screening (Shapiro et al., 2012). Uptake of CRC screening 
has improved year after year, but in 2015, only 62% of eligible adults were up to date with CRC 
screening. The National Colorectal Cancer Roundtable’s 80% by 2018 initiative will not likely 
be met, even in the northeastern New England states, which have the highest screening rates, 
with Massachusetts ranking first at 76% overall in 2015. Notably, screening rates are 
significantly higher after age 65 compared to ages 50-64, 68% and 58% nationally, respectively. 
(American Cancer Society, 2017) 
 7 
 
In addition to age, race/ethnicity factors into CRC screening prevalence: Hispanics and 
Asians have the lowest rates (49% each), followed by American Indian/Alaskan Natives (54%), 
NHBs (62%), and NHWs (65%). Other factors include education and nativity. College graduates 
have relatively higher screening compliance at 71%, and immigrants who have been in the US 
for less than 10 years have very low screening, at only 34% of eligible adults. Increasing CRC 
cancer screening remains a cancer prevention priority, as compliance rates are lower than other 
cancer screenings, such as breast (64%) and cervical (81%) (American Cancer Society, 2017).  
1.6 Research Objectives 
The two research objectives in this dissertation fill gaps in the literature. Project 1 
examines variations in the association between level of educational attainment and CRC 
mortality; Project 2 examines the determinants of disparities in CRC survival.  
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Chapter 2. Background and Significance 
 
2.1 Project I: Colorectal Cancer Mortality and Education 
2.1.1 Education: Proxy for Socioeconomic Status? 
The health benefits of higher socioeconomic status (SES) have been well-documented 
(Adler & Ostrove, 1999; Goldman & Smith, 2011). While income, occupational status, and 
relative position have all been used as individual-level or aggregate measures of SES, education 
level is often considered the best single measure when looking at the association with health 
because it is usually completed relatively early in life and subsequently remains stable 
throughout life (Baker, Leon, Smith Greenaway, Collins, & Movit, 2011). Alternatively, income, 
occupation, and relative position can vary throughout the lifetime, and are often influenced by 
health. Moreover, education is often a precursor to the other measures (Braveman et al., 2005). 
However, childhood health can also interfere with educational attainment, whether through low 
birthweight or chronic stress from adverse childhood events associated with low SES; thus, some 
portion of the relationship between health and education or other measures of SES may reflect 
reverse causality (Zimmerman, Woolf, & Haley, 2015).  
Nonetheless, in the US, to examine the relationship between SES and CRC on a 
population basis using individual-level data, existing studies have used education as a proxy for 
SES and have used CRC mortality as the outcome (Albano et al., 2007; Jemal et al., 2015; 
Kinsey, Jemal, Liff, Ward, & Thun, 2008; Siegel, Ward, Brawley, & Jemal, 2011; Steenland, 
Henley, & Thun, 2002), The selection of education with mortality is likely driven by the facility 
of obtaining these at an individual level in the United States, since education is a required field 
on death certificates (Olshansky et al., 2012). Many other studies use education, income, 
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poverty, and/or other SES measures at an ecological level, by neighborhood, census tract or 
county. This aggregated data is relatively easily available from census data and thus, these 
studies vary in whether the outcome measure is CRC incidence, survival, or mortality (Clegg et 
al., 2009; Clouston et al., 2017; Doubeni et al., 2012; Du et al., 2007; Krieger et al., 1999; Le, 
Ziogas, Lipkin, & Zell, 2008; Lee et al., 2012; Leufkens et al., 2012; Lian et al., 2011; Manser & 
Bauerfeind, 2014; Mouw et al., 2008; Saldana-Ruiz et al., 2013; Siegel, Jemal, Thun, Hao, & 
Ward, 2008; Singh & Jemal, 2017; Singh, Miller, & Hankey, 2002; Singh, Williams, Siahpush, 
& Mulhollen, 2011; Steinbrecher et al., 2012; Tao, Ladabaum, Gomez, & Cheng, 2014; Weir, Li, 
Henley, & Joseph, 2017).  These studies have demonstrated that the relationship between SES 
and CRC is complex, varies by sex, race/ethnicity, urbanicity, and geographic region of the US. 
Nonetheless, the prevailing pattern is that higher SES is associated with lower incidence, higher 
survival, and lower mortality from CRC.   
2.1.2 Potential Pathways between Education and Colorectal Cancer Outcomes 
Many pathways have been proposed to explain the mechanisms by which education 
confers health benefits; indubitably these pathways differ by important demographic factors 
including age, birth cohort, sex, race/ethnicity as well as immigrant status and associated 
acculturation factors (Baker et al., 2011; Berkman, Kawachi, & Glymour, 2014; Braveman et al., 
2005; Saldana-Ruiz et al., 2013). At the individual level, benefits conferred by education may 
include not only more advanced math, reading, and science/health literacy but also “soft skills” 
such as higher-level thinking, decision-making, communication skills and style, and increased 
self-efficacy (Berkman et al., 2014; Zimmerman et al., 2015). Education also influences other 
important factors including income and access to social networks, both of which have been 
shown to influence health outcomes. Additionally, education is linked to health behaviors, both 
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at the individual and the community-level, including diet, exercise, smoking and alcohol 
consumption, behaviors that are associated with CRC risk. Community factors, although more 
difficult to measure, also impact CRC risk. Men and women with lower levels of education often 
live in areas with fewer resources including healthy food environments and quality health care 
facilities. Their communities also likely have less political capital to advocate for changes that 
would favorably impact their health outcomes. Thus, the pathways by which education impacts 
CRC mortality are numerous and complex (Berkman et al., 2014; Zimmerman et al., 2015).     
2.1.3 Education and Colorectal Cancer Mortality 
To our knowledge, the earliest study that looked specifically at the association between 
CRC and mortality was conducted in Italy analyzing data from 1981; their findings were mixed. 
Among women, the risk of colon cancer was 63% lower for those with lower education levels; 
however, there was no association found between education and colon cancer for men, and none 
found for men or women with rectal cancer (Faggiano, Partanen, Kogevinas, & Boffetta, 1997). 
Similarly, mixed results were found in Norway; a cohort from 1970-1979 showed 20% lower 
mortality for men with lower education, but no significant association was found in three 
subsequent cohorts. Among women, no association was found until the last cohort studied, 2000-
2002, in which a trend reversal appears, showing an inverse gradient as women with more 
education had 24% higher mortality than those with less (Elstad, Torstensrud, Lyngstad, & 
Kravdal, 2011). The negative association between education and CRC mortality was also seen in 
Lithuania using data from 2000-2002, with the lowest educated men experiencing 32% lower 
mortality (Ezendam et al., 2008).  
Multiple other studies have been conducted since then analyzing deaths in European 
countries, including Belgium, Estonia, Finland, France, Italy, Lithuania, Norway, Poland, Spain, 
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and Sweden (Elstad et al., 2011; Ezendam et al., 2008; Menvielle et al., 2008; Menvielle, 
Leclerc, Chastang, & Luce, 2006; Menvielle, Rey, Jougla, & Luce, 2013; Puigpinos et al., 2009). 
All have either shown either no association or an inverse gradient, with higher mortality risk seen 
for those with lower education. The most recent studies, conducted with deaths occurring after 
2000, consistently show a significant inverse gradient for men, but a weaker association for 
women (Alicandro et al., 2017; Jasilionis, Smailyte, Vincerzevskiene, & Shkolnikov, 2015; 
Vanthomme, Vandenheede, Hagedoorn, & Gadeyne, 2017).   
A few other studies have been conducted in non-European countries including New 
Zealand (Shaw, Blakely, Sarfati, Fawcett, & Peace, 2006), Japan (Nishi et al., 2008), Colombia 
(de Vries et al., 2015). None of these found a significant association between CRC mortality and 
level of education.   
In the United States, only a handful of studies have examined the association between 
education and CRC mortality; most have come from researchers at The American Cancer 
Society. The very first cohort analyzed to our knowledge were decedents from 1959-1972 and no 
association was found (Steenland et al., 2002). Likewise, a recent analysis of a 1973-1979 cohort 
found no association between CRC mortality and educational attainment for women, although 
the inverse gradient was found for men (Singh & Jemal, 2017). However, since then, a consistent 
inverse gradient has been found for both men and women, as well as for black and white 
populations in the US. Estimates range from 40%-160% higher risk of CRC mortality for those 
in the lowest educational levels compared to the highest (Albano et al., 2007; Jemal et al., 2015; 
Siegel et al., 2011; Singh & Jemal, 2017; Steenland et al., 2002; Weir et al., 2017). One notable 
exception is that results are mixed for Hispanics, with two studies showing no association for 
Hispanic women (Siegel et al., 2011; Weir et al., 2017); one showing in the inverse gradient only 
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for Hispanic men (Siegel et al., 2011), and one showing the inverse gradient for both Hispanic 
men and women (Jemal et al., 2015).  
Additionally, one study showed that temporal trends in CRC mortality from 1993-2001 
varied by level of education. Mortality declines were only seen consistently among those with 
higher education levels (Kinsey et al., 2008). Among whites, rates decline by 1-3% for those 
with more than a high school education but remained stable for those with less. Among blacks, 
declines were only seen for those with 16+ years of education but these reductions were sizable, 
up to 5%. However, rates were stable those with at least 12 years educational attainment and 
increased over time by 3% for blacks with less than a high school education (Kinsey et al., 
2008).  
2.1.4 Gaps in Knowledge  
The association between educational attainment and CRC mortality has generally been 
characterized as inverse in modern times, albeit some evidence suggests low levels of education 
were associated with low CRC mortality in Europe before 1980. In the US, previous research has 
found variation in the magnitude of the inverse association by sex and by race/ethnicity. 
However, to our knowledge, the association has never been characterized for Asian populations 
in aggregate, and certainly not by specific Asian subgroup. Moreover, no consistent association 
has been found for Hispanics, which we suspect may be due to the aggregation of US-born and 
foreign-born Hispanics. To our knowledge, no research to date has examined how the association 
between CRC mortality and education may differ in either magnitude and/or direction by 
birthplace among Asian and Hispanic minority populations in the US. The proposed research 
will fill these gaps in knowledge.  
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2.2 Project II: Colorectal Cancer Survival in Nevada 
2.2.1 Nevada’s Known Colorectal Cancer Profile 
As a Mountain West state, Nevada would be expected to have a relatively lower burden 
of cancer in the United States (Siegel et al., 2018). Unfortunately, Nevada stands in stark contrast 
to its neighbors for mortality from many cancers (Pinheiro, Reid, Saccucci, Harris, & Guinan, 
2012). Overall age-adjusted cancer incidence in Nevada from 2010-2014 was 508 and 403 per 
100,000 for men and women, respectively. Nevada ranked 24th among all US states and the 
District of Columbia for males; the Nevada rate was higher than the US rate of 501 per 100,000. 
However, Nevada ranked 12th for females; the rate was lower than the overall US rate of 418 per 
100,000. Similarly, overall cancer mortality rates among Nevada men were ranked 17th and were 
somewhat lower than the US rate. In contrast, however, overall cancer mortality rates for women 
in Nevada ranked 32nd and were higher than US rates. On the other hand, all five of Nevada’s 
neighboring states, California, Utah, Oregon, Idaho, and Arizona, rank among the lowest for 
cancer incidence and mortality in the nation (Siegel et al., 2018).  
For CRC specifically, Nevada’s documented incidence and mortality burden significantly 
exceed the overall US burden for both men and women. Men have incidence and mortality of 
50.7 and 19.6 per 100,000, respectively, ranking 42nd in CRC incidence and 44th in CRC 
mortality. Women have incidence and mortality of 36.4 and 12.2 per 100,000, respectively, 
ranking 33rd in CRC incidence and 44th in CRC mortality (Siegel et al., 2018).  
These CRC rates are primarily driven by the majority NHW population, as Hispanics and 
NHB in Nevada fare relatively well compared to their counterparts in other states. While 
incidence for NHB men and women in Nevada is somewhat higher than the US rate for NHBs; 
mortality is lower than their US counterparts. For Hispanics, the advantage is confined to men, 
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who have both lower CRC incidence and lower CRC mortality than the US Hispanic rate. 
Conversely CRC incidence and mortality rates among Hispanic women are higher than their 
Hispanic counterparts in the US (Siegel et al., 2017). 
Screening for CRC is very low in Nevada, which ranked 48th in the nation in 2016 with only 
64% of the population up to date with CRC screening. Notably, only 56% of those ages 50-64 
had received CRC screening, while 74% of adults 65 and older were screened (American Cancer 
Society, 2017). One local cancer report from the Nevada Central Cancer Registry in 2012 
reported that screening prevalence was significantly higher in the northwestern Washoe County 
than in populous Clark County and all other counties combined. Correspondingly, they reported 
significant differences by geographic region in CRC stage at diagnosis in 2009. While Washoe 
County had 72.5% of tumors diagnosed at local or regional stages, which have a more favorable 
prognosis, Clark County only had 62.9% and the other counties combined had 69.9%. Moreover, 
Clark County had a disproportionately large share of unstaged tumors (Nevada Central Cancer 
Registry, 2012). Local efforts to increase CRC screening are in place (Colorectal Cancer Control 
Program, 2016), and significant improvements have been made in the past decade (Ponce & 
Kuzhippala, 2015). Nonetheless, additional gains will be required to maximize CRC survival, 
and reduce incidence and mortality.      
2.2.2 Nevada’s Cancer Survival Disparities 
Survival from CRC has been estimated at a national level and for those states associated 
with the Surveillance, Epidemiology, and End Results Program (SEER) cancer registry program 
(Jemal, Ward, Johnson, Cronin, Ma, Ryerson, Mariotto, Lake, Wilson, Sherman, et al., 2017). 
Calculating survival from cancer registries associated with the CDC’s National Program for 
Cancer Registries (NPCR) is more challenging because most NPCR registries, including Nevada, 
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have only passive follow-up methods. Cancer cases are presumed alive if not found dead through 
linkages, which differs from active follow-up in SEER registries where 95% of cases must be 
followed up (Johnson, Weir, Yin, & Niu, 2010; Weir et al., 2014). In Nevada, linkages are only 
typically made with the state vital statistics data, leading to a further challenge as many cases 
may die in other states. In Nevada, one previous study examined CRC survival but was subject to 
these methodological concerns (Wassira, Pinheiro, Symanowski, & Hansen, 2013). 
To overcome these barriers, researcher Paulo S. Pinheiro, formerly at the University of 
Nevada Las Vegas, used grant funds to procure linkages between Nevada’s Central Cancer 
Registry data and the National Death Index. From those linkages, two survival projects were 
conducted that produced accurate survival proportions for Nevada, one for breast and one for 
lung (Callahan et al., 2017; Osuoha, Callahan, Ponce, & Pinheiro, 2018). The current project 
constitutes the third to benefit from those linkages.  
Compared to the national lung cancer survival estimates, Nevada’s survival was slightly 
(but not statistically significantly) lower for all race/ethnicities except for NHW men (Osuoha et 
al., 2018). For breast cancer, survival among Nevadan women was significantly lower than the 
US; however further analyses stratified by geographic region of Nevada showed that this 
disparity was only for Southern and rural Nevada; breast cancer survival for women in 
Northwestern Nevada was equivalent to national proportions. Strikingly lower survival was 
noted in Southern Nevada for women diagnosed at regional and distant stages compared to 
national counterparts (Callahan et al., 2017).   
Within-state regional disparities were found in both the breast and lung cancer survival 
projects. Cancer patients in Southern Nevada, or Clark County, fared far worse than those in 
Northwestern Nevada, which includes Washoe County. Women in Clark County had a 16% 
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higher risk of death than women diagnosed in Northwestern Nevada even after controlling for all 
relevant covariates (Callahan et al., 2017). For lung cancer, patients had a 9% higher risk of 
death in the South (Osuoha et al., 2018).  
Racial/ethnic disparities were found for NHB women for breast cancer, but no discernible 
differences were noted for lung cancer between NHB and NHWs. Asians and Hispanics had 
higher lung cancer survival than NHWS, but all other racial/ethnic groups besides NHBs had 
similar breast cancer survival to NHWs in Nevada. Other findings were expected: better lung 
cancer survival for women than men; better survival for married men and women; better breast 
and lung cancer survival for earlier stages at diagnosis; lower survival with increasing age; lower 
survival for patients in low SES zip codes; and lower survival for patients with no insurance or 
Medicaid (Callahan et al., 2017; Osuoha et al., 2018). Notably, the lung cancer study examined 
receipt of surgery for indicated tumors and found that Southern Nevadans were far less likely to 
get appropriate, potentially lifesaving, surgical treatment (Osuoha et al., 2018).    
2.2.3 Determinants of Colorectal Cancer Survival 
The strongest predictor of survival from CRC, as for most cancers, is stage at diagnosis 
(Brenner et al., 2012; Lai, Wang, Civan, Palazzo, Ye, Hyslop, Lin, Myers, Li, & Jiang, 2016; 
Lansdorp-Vogelaar et al., 2012; Siegel et al., 2017). Many disparities in CRC survival and 
mortality can be attributed to differences in stage distribution by population groups. One study 
showed that thirty-six percent of the disparity between whites and blacks in CRC mortality could 
be attributed to differences in stage-specific relative CRC survival (Lansdorp-Vogelaar et al., 
2012). Screening has the potential to detect CRC tumors at an earlier stage, but some 
populations, including those with lower educational attainment as well as immigrant groups, 
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have lower screening rates, which also impacts their survival (Clegg et al., 2009; Ward et al., 
2004).  
Several tumor characteristics are determinants of CRC survival, including tumor location 
(rectum or colon; left or right) and molecular types. All-stages-combined survival is somewhat 
higher for rectum cancer than colon cancer in the US, which is largely explainable by the higher 
proportion of localized rectal tumors; stage-specific survival has typically been found to be 
higher for colon than rectum (Siegel et al., 2017). However, some studies have shown better 
survival for colon cancer than rectal (Brenner et al., 2012). Right-sided, or proximal, colon 
cancer has worse survival than left-sided, or distal, even after adjusting for stage and treatment 
(Benedix et al., 2010; Brenner et al., 2012; Meguid, Slidell, Wolfgang, Chang, & Ahuja, 2008; 
Siegel et al., 2017). Most CRC tumors are adenocarcinomas (ADKs); patient with ADKs that are 
mucinous have lower survival (Negri et al., 2005). Several tumor markers also negatively 
influence survival, including microsatellite stability, CpG island methylator phenotype, and/or 
having for the BRAF and/or KRAS mutation (Phipps et al., 2015; van Rijnsoever, Elsaleh, 
Joseph, McCaul, & Iacopetta, 2003).  
Several demographic factors impact CRC survival, including sex, age, and race/ethnicity. 
Unlike many cancers, for which women have a survival advantage, men and women in aggregate 
in the US have approximately equivalent CRC survival (Siegel et al., 2017). However, studies in 
Europe have shown an advantage for women (Brenner et al., 2012). Age is a strong determinant 
of CRC survival, consistent with most cancers; increasing age leads to lower survival (Brenner et 
al., 2012; Siegel et al., 2017). General decline in physiological functioning as well as increases in 
comorbid conditions likely explain this disadvantage by age. Also, one study showed that older 
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patients are less likely to receive chemotherapy and/or radiation (Murphy, Harlan, Lund, Lynch, 
& Geiger, 2015).  
Studies examining racial/ethnic differences in CRC survival in the US have shown the 
most favorable survival profiles for API and Hispanic populations in aggregate, followed by 
NHW. Worse survival is seen for NHB and AI/AN populations (Doubeni et al., 2007; Siegel et 
al., 2017). Many racial/ethnic disparities are linked to socioeconomic inequalities that impact 
differences in screening and treatment access (Du et al., 2007; Du, Meyer, & Franzini, 2007; Lai 
et al., 2016; Le et al., 2008; Siegel et al., 2017; White, Vernon, Franzini, & Du, 2010). 
Researchers also examined survival differences among Asians by specific race and found CRC 
survival among Filipino men not only to be lower than their Chinese and Japanese counterparts, 
but also lower than NHWs. Highest survival was seen among Japanese men and women (Lin et 
al., 2002).     
Place of residence, or geography, has also been associated with CRC survival. Patients in 
rural areas have worse outcomes than patients in urban areas (Henley et al., 2017; Hines, 
Markossian, Johnson, Dong, & Bayakly, 2014; Siegel, Fedewa, et al., 2015; Singh et al., 2011). 
However, one recent US study showed that rural and urban patients under access to similar care 
in clinical trials had similar survival outcomes (Unger et al., 2018), suggesting that the 
rural/urban survival disparities are driven by access to care factors. Additionally, studies across 
the globe have shown sharp differences in CRC survival, with the highest survival, over 70% for 
both colon and rectum cancers, documented recently in Korea and Australia; not surprisingly, the 
worst CRC survival is found in low to middle-income countries (Allemani et al., 2018). Within 
the US, CRC mortality hotspots have been identified by spatial mapping in the Lower 
 19 
 
Mississippi Delta, west central Appalachia, and eastern North Carolina/Virginia, consistent with 
findings of worse survival outcomes for those in rural areas (Siegel, Robbins, & Jemal, 2015). 
Comorbidities play a role in CRC survival; patients with many comorbidities have worse 
outcomes (Brenner et al., 2012; Edwards et al., 2014; Gross et al., 2006). For example, having 
two or more comorbid conditions is associated with 43% decreased likelihood of receiving 
chemotherapy with stage III colon cancer, which would decrease survival (Murphy et al., 2015). 
In particular, diabetes has been shown to adversely impact survival (Luo, Lin, He, & Hendryx, 
2014), potentially mediating the differential survival outcomes by race (Waheed, Azad, Waheed, 
& Yeh, 2014) and age (Brenner et al., 2012).   
Receiving appropriate and timely treatment after a CRC diagnosis is also linked to 
improved survival and may explain some of the previously mentioned disparities by geography, 
race/ethnicity, and SES. One study demonstrated a 14% decrease in overall survival after CRC 
resection for every month delay in receiving adjuvant chemotherapy (Biagi et al., 2011). Other 
studies have shown that patients from low SES areas were significantly less likely to receive 
adjuvant chemotherapy after resection for regional stage CRC than their higher SES counterparts 
(Byers et al., 2008), and significantly less likely to receive chemotherapy for any stage if on 
Medicaid (Butler et al., 2013). Additionally, CRC survival is linked to insurance status, with 
uninsured and patients with Medicaid having the worst outcomes (Roetzheim et al., 2000).  
Several studies have examined patterns of CRC care to explain racial survival disparities 
(Baldwin et al., 2005; Butler et al., 2013; Murphy et al., 2015). NHBs and Hispanics with CRC 
are 42% less likely to receive surgical resection (Haas et al., 2011), and 20% less likely to 
receive chemotherapy than their NHW counterparts (Murphy et al., 2015).  Interestingly, one 
study found that NHB were equally as likely as NHWs to receive consultation with an medical 
 20 
 
and/or radiation oncologist for rectal cancer, but less likely to receive chemotherapy and/or 
radiation, suggesting patient preferences, provider decisions, and patient–provider interactions 
may play a role in the racial disparities seen in receipt of treatment (Morris et al., 2008). A few 
studies have shown that outcomes are similar, or disparities are significantly reduced, between 
NHBs and NHWs after adjustment for stage and treatment (Dominitz, Samsa, Landsman, & 
Provenzale, 1998; Le et al., 2008).  
Some researchers have examined other factors that are associated with improvements in 
CRC survival. In particular, regular aspirin use after CRC diagnosis has been associated with 
reduced CRC mortality for AJCC stages I, II, and III (Chan, Ogino, & Fuchs, 2009). However, 
the benefits may be limited by CRC tumor type (Chan et al., 2009; Liao et al., 2012). Lastly, 
physical activity, known to be protective for CRC incidence (Huxley et al., 2009), has also been 
examined for its protective effect against CRC mortality. Campbell et al. found that post-
diagnosis physical activity at recommended national guidelines of 150 minutes per week was 
associated with better CRC survival compared to lower levels of exercise (Campbell, Patel, 
Newton, Jacobs, & Gapstur, 2013).   
2.2.4 Gaps in Knowledge 
To date, no study has accurately and comprehensively characterized survival from CRC 
in Nevada. The state of Nevada has a population of nearly 3 million, almost half of whom are 
minorities, and has seen an 11% population growth since 2010. Knowing what drives Nevada’s 
CRC burden is critical to meeting the cancer control and prevention needs of its diverse and 
burgeoning population. Thus, the second study of this dissertation will provide critical 
information about the determinants of survival in Nevada, while also identifying any within-state 
disparities.   
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Chapter 3. Methods 
 
3.1 Project 1: Colorectal Cancer Mortality and Education 
3.1.1 Research Aims  
To characterize the association between education level and CRC mortality among decedents in 
California (2012-2017) by race/ethnicity. 
3.1.2 Research Hypotheses  
1. H0: There will be no significant differences in CRC mortality by education level among 
[each race/ethnicity group].  
HA: There will be significant differences in CRC mortality by education level among 
[each race/ethnicity group]. 
2. H0:  There will be no significant differences in CRC mortality between race/ethnicity 
groups at [each given education level].  
HA: There will be significant differences in CRC mortality between race/ethnicity groups 
at each given education level].  
3.1.3 Theoretical Framework 
These studies are proposed within the framework of the Fundamental Cause Theory, 
which proposes SES as a fundamental cause of disease. Under this framework, the association 
between SES and mortality endures not only because the access to resources and beneficial 
social conditions are associated with higher levels of education, but also because over time, 
technological changes occur to improve health outcomes, and these are disproportionately 
accessed by higher SES populations than by their lower SES counterparts (Link, Northridge, 
Phelan, & Ganz, 1998; Phelan, Link, Diez-Roux, Kawachi, & Levin, 2004; Saldana-Ruiz et al., 
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2013). In the case of CRC, these advances include population screening to prevent CRC and 
improve survival through the identification of tumors in the localized stage, and well as 
treatment advances after a CRC diagnosis, including access to clinical trials. Researchers have 
used the diffusion of technologies model to propose that better educated people may be better 
informed about health-related innovations and/or may be more adept or willing to accept new 
technologies and/or may have more access to high-quality providers that embrace new 
technologies (Chang & Lauderdale, 2009; Glied & Lleras-Muney, 2008). Moreover, the 
Fundamental Cause Theory has been tested to show that education level mortality disparities are 
wider for diseases for which there exists solid knowledge on how to prevent and/or treat them 
(Phelan et al., 2004; Tehranifar et al., 2016). For this project, we assume that CRC is somewhat 
preventable and treatable, and therefore, we expect to see higher mortality for lower educated 
persons. However, it remains to be seen whether this theory adequately captures the experience 
of diverse populations within the US. 
3.1.4 Data Sources 
For this cross-sectional study, six years of cancer mortality data (January 1st, 2012 
through December 31st, 2017) for all California residents were obtained from the California 
Department of Public Health. Selected cases had CRC as a primary cause of death, identified by 
the International Statistical Classification of Diseases 10th revision, using codes C.18-C20 
(World Health Organization, 2004). Population denominators from each single year of the US 
Census Bureau’s American Community Survey for California were retrieved using the IPUMS 
interface for Census microdata (Ruggles, Genadek, Goeken, Grover, & Sobek). Data were 
retrieved by sex, race/ethnicity (including distinct subgroups), birthplace and age group; these 
were pooled to provide denominators for sex years of cancer counts. 
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3.1.5 Protection of Human Subjects 
 In California, Protocol # 15-08-2161 for Principal Investigator Paulo S. Pinheiro at the 
University of Miami was approved by the Committee for the Protection of Human Subjects, 
under the California Health and Human Services Agency. Additionally, the IRB at the University 
of Nevada Las Vegas conducted an Administrative Review of Protocol 1214294-1 and 
determined that it did not meet the definition of human subjects’ research and was thus excluded 
from official review.  
3.1.6 Analytical Methods  
3.1.6.1. Data Coding and Preparation  
Accurate classification of race/ethnicity, including specific group affiliation, was 
obtained for population data as well as cancer deaths by careful examination of all race, 
ethnicity, and birthplace codes, including text fields. Within each of the four major race 
categories (White, Black, American Indian/Alaskan Native, Asian and Pacific Islander), 
Hispanics were extracted to form a unique group resulting in five mutually-exclusive major 
race/ethnicity groups: Hispanic (of any race) and white, black, AI/AN, and Asian/Pacific 
Islander, all non-Hispanic. Subsequent coding was based on race/ethnicity descriptors and 
birthplace, (to enhance identification if decedent was foreign-born), to determine assignment into 
one of the major racial/ethnic Hispanic or API subgroups. APIs were identified as Chinese, 
Japanese, Filipino, South Asian (including birthplace of Nepal, India, Bangladesh, Pakistan, and 
Sri Lanka), Korean, Vietnamese, and all others. Among Hispanics, Mexicans were the largest 
group. As prior research has demonstrated striking differences in cancer outcomes between 
Mexican Americans, born in the US, and Mexican Immigrants, born in Mexico, (Pinheiro, 
Callahan, Gomez, et al., 2017; Pinheiro, Callahan, Stern, & de Vries, 2018), these two groups 
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were considered separately. Other distinct Hispanic groups included Puerto Rican, Cuban, 
Dominican, and Spaniard. Lastly, Central American and South American groups were formed to 
account for origin in a Central American or South American Spanish-speaking country.  
After classification of Hispanics into these eight mutually-exclusive categories, 392 
deaths remained, representing the Hispanic NOS cases, accounting for 6.3% of all Hispanic 
deaths. In the population data, 2.2% of all Hispanic cases were Hispanic NOS, of which ¼ were 
foreign-born. To avoid underestimation, especially of the large Mexican American group, by 
excluding these NOS cases, these were proportionally partitioned by sex, age group, education 
level, and birthplace into existing Hispanic groups.  
Educational level was classified into 3 groups: less than high school; high school or 
equivalent, including up to 2 years of college but no conferred degree; and associate’s degree or 
more than 2 years of college and higher. Age was recoded into 18 age bands, each 5-year except 
the last, which includes ages 85 and older.   
A negative binomial regression file was prepared with rows for each count of CRC deaths 
and corresponding denominators for each sex, major race/ethnicity group, detailed race/ethnicity 
subgroup, 5-year age group, education level, and birthplace (only used for partition of NOS 
cases).  
3.1.6.2. Data Analysis  
To develop mortality rate ratios, negative binomial regression models were used. 
Negative binomial is a generalized linear regression model based on a negative binomial 
distribution and a log-link. It is a modification of Poisson regression, used to model discrete 
counts, such as number of deaths, when the assumption of equi-dispersion (mean=variance) is 
not met (Coxe, West, & Aiken, 2009; Gardner, Mulvey, & Shaw, 1995). Because we specifically 
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modeled rates, an offset term reflecting the population denominator for each count was added in 
the form of the natural log of the denominator. The resulting effect sizes, or betas, were 
exponentiated to obtain mortality rate ratios, with a specified reference group. Figure 1 is a 
simple depiction of one of our regression models. 
 
Counts:      
ln(μ) =  β0 + β1*R/ENHW + β2*R/EHispanic + β3*EDUChigh + β4*EDUCmedium + β5*EDUClow + β6·AGE8 + 
β7·AGE9 +... β15·AGE18   
 
Rates: 
ln(μ/t)= ln(μ) - ln(t) 
ln(μ) = β0 + β1*R/ENHW + 
β2*R/EHispanic+β3*EDUChigh+β4*EDUCmedium+β5*EDUClow+β6·AGE8+β7·AGE9+... β15·AGE18+ln(t)  
 
Figure 1: Negative binomial regression models for rates 
As expected, preliminary models showed a significant interaction between major 
race/ethnicity group and education level; thus, models were stratified. To assess the first 
hypothesis, models stratified by race/ethnicity examined the relationship between education level 
and CRC mortality for each distinct race/ethnicity group. To assess the second hypothesis, 
models stratified by education level examined whether mortality risk differed by race/ethnicity at 
each educational level. Differences in mortality rate ratios were considered significant if p-values 
were <.05 and/or confidence intervals did not include the null. As multiple cells in younger age 
groups were empty, models included only ages 35 and above. 
All analyses were conducted with either SAS 9.4 (SAS Institute Inc., Cary, NC) or 
IBM SPSS Version 18.0.  
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3.2 Project 2: Colorectal Cancer Survival in Nevada 
3.2.1 Research Aims  
1. To characterize the 5-year cause-specific survival of Nevada residents from a CRC 
diagnosis and compare to US survival. 
2. To examine any demographic, social, or clinical factors impacting CRC survival in 
Nevada. 
3.2.2 Research Hypotheses 
1. H0: There will be no significant differences in CRC survival in Nevada overall and 
among [each race/ethnic group] compared to their national counterparts. 
HA: There will be significant differences in CRC survival in Nevada overall and among 
[each race/ethnic group] compared to their national counterparts. 
 
2. H0: There will be no significant differences in CRC survival in Nevada by [race/ethnicity 
and/or region of Nevada] after adjustment for the analyzed demographic, social, or 
clinical factors. 
HA: There will be significant differences in CRC survival in Nevada by [race/ethnicity 
and/or region of Nevada] after adjustment for the analyzed demographic, social, or 
clinical factors 
3.2.3 Theoretical Framework  
(as above, see section 3.1.3) 
3.2.4 Data Sources 
Data were obtained from the Nevada Central Cancer Registry (NCCR), which collects 
cancer incidence data in Nevada using standards established by the National Program for Cancer 
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Registries (NPCR) (National Program of Cancer, 2013) and the North American Association of 
Central Cancer Registries (NAACCR) (Hofferkamp, 2008). To minimize the number of missing 
deaths, customary death record linkages with the Nevada Office of Vital Records were 
augmented by linkages with the National Death Index. Cases of first primary CRC, inclusive of 
ICD-O-3 codes C18-C20.4 (World Health Organization, 2013), diagnosed in the state of Nevada 
between 2003-2013 were included in this study.  
3.2.5 Protection of Human Subjects  
University of Nevada Las Vegas’ IRB conducted a Review of Protocol 858093-1 and 
determined that it was exempt from review.  
3.2.6 Analytical Methods  
3.2.6.1 Data Coding and Preparation 
Variables included were demographic, social, and pathological factors ascertained at date 
of diagnosis and assessed for their impact on CRC survival. The International Cancer Survival 
Standards age classification (Corazziari, Quinn, & Capocaccia, 2004) system was used; the 
resulting five age categories were 15-44, 45-54, 55-64, 65-74, and 75+. Cases were classified 
into six mutually exclusive racial/ethnic groups: NHW, NHB, Hispanic, American Indian/Alaska 
Native (AI/AN), Filipino, and other Asian (Chinese, Japanese, Korean, Indian, etc.). Filipinos 
were considered separately since they account for 67% of Nevada’s overall Asian population 
(Flanagan & Hardcastle, 2014). Place of residence in Nevada was divided into three distinct 
geographic regions. Southern Nevada is comprised of populous Clark County, which includes 
Las Vegas and the surrounding areas. The Northwestern Nevada region represents the only other 
large population area in Nevada, encompassing the capital, Carson City, as well as Douglas, 
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Lyon, Storey and Washoe counties. The remaining eleven sparsely populated rural and frontier 
counties were classified as Rural Nevada.  
Social factors included were insurance type, marital status, and SES. Insurance categories 
included private, Medicare, Medicaid, uninsured, and unknown. Marital status was classified as 
follows: married, single, divorced/separated, widowed, or unknown. Proportion of people living 
in poverty in a patient’s zip code of residence was used as a proxy for SES; less than 5% poverty 
in zip code of residence was considered high SES, between 5-10% was medium SES, and over 
10% was low SES.  
Tumor stage at diagnosis was coded either I, II, III, or IV, according to guidelines set by 
the American Joint Committee on Cancer (Amin et al., 2017);  however, for stage-specific 
survival comparisons with national survival estimates, SEER Summary Staging (Fritz et al., 
2001) of localized, regional, and distant groups was used. Anatomic sublocations considered 
were right colon (C18.0-18.3), left colon (C18.4-18.7); colon NOS (C18.8, C18.9), and rectum 
(C19.9, C20.9) (World Health Organization, 2013). Morphologies included adenocarcinomas 
(ADKs) and others, ADKs in adenoma/polyps, Mucinous ADKs, Carcinoids NOS, and 
Unusuals.  
Treatment according to guidelines (TAG) was assessed for AJCC Stage I-III tumors by 
determining whether radiation, chemotherapy and surgery were received in accordance with 
guidelines developed by The American Society of Colon and Rectal Surgeons (Monson et al., 
2013; Vogel, Eskicioglu, Weiser, Feingold, & Steele, 2017) (Table 3).  
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Table 3: Minimum requirements for Treatment According to Guideline designations for 
AJCC Stages I-III CRC tumors. 
Stage Colon Cancer C18.X Rectal Cancer C19.9 & C20.9 
AJCC I surgery surgery 
AJCC II surgery surgery, radiotherapy & chemotherapy 
AJCC III surgery & chemotherapy surgery, radiotherapy & chemotherapy 
 
3.2.6.2 Data Analysis 
Five-year cause-specific survival from CRC was calculated, age-adjusted and stratified by 
race/ethnicity (all stages) and region of Nevada (stage-specific), using the life table method, 
which facilitated comparisons between Nevada and the US nation, represented by survival 
calculated with the SEER-18 catchment area data for the same years as our study, 2003-2013 
(Howlader, Noone, & Krapcho, 2018). Survival time was measured in months from the date of 
diagnosis until either the date of death or the end of the study period, Dec 31, 2014, whichever 
occurred first. For censored observations, the presumed alive assumption was used. Cases 
diagnosed by death certificate or autopsy only, as well as cases with a negative or missing 
survival period, were excluded from survival analyses.  
 To calculate risk of death specifically from CRC, and identify factors impacting survival, 
Cox proportional hazards regression models for multivariate survival analysis were constructed, 
adjusting for all covariates significant in previous univariate analyses. Hazard ratios and their 
corresponding 95% confidence intervals (CI) were computed. Separate models were constructed 
to examine risk by region of Nevada and TAG for cases diagnosed in AJCC stages I-III who had 
complete information on treatments.  
Statistical tests with p-values <0.05 were considered statistically significant. IBM SPSS Version 
18.0 was used for all data analyses. 
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Chapter 4. Results 
 
4.1 Project 1: Colorectal Cancer Mortality and Education 
4.1.1 Study Population  
A total of 31,159 deaths from CRC occurred between 2012 and 2017 in California; 
approximately 58% of decedents were non-Hispanic white, 19% were Hispanic, 13% were 
Asian/Pacific Islander, 8% were non-Hispanic black, 0.6% were American Indian/Alaskan 
Native and 0.5% were of unknown race/ethnicity. For the same time period, the average annual 
population in California was approximately 38.9 million. Discrepancies between the proportions 
of deaths in each race/ethnicity and the corresponding population proportion can be explained by 
differences in population age structure; NHWs in CA are generally older, while Hispanics are 
younger. (Table 4).  
Table 4: Total population and CRC cancer deaths in California. 2012-2017. 
 Race/Ethnicity Average Annual Population % Cases % 
Non-Hispanic White                   14,754,325  38%      18,168  58% 
Non-Hispanic Black                     2,483,086  6%        2,569  8% 
American Indian/Alaskan Native                        297,531  1%           185  0.6% 
Asian/Pacific Islander                     6,029,123  16%        4,077  13% 
Hispanic*                   15,087,681  39%        6,019  19% 
Other/Unknown                        199,577  1%           141  0.5% 
Total                    38,851,323         31,159    
Some cases, a total of 3.3%, were excluded from analyses. 326 unknown race and AI/AN cases 
were excluded; AI/AN cases were too few for stand-alone analysis. Cases with missing 
educational level in the data were also excluded (n=340). Finally, 313 deaths occurring in age 
groups younger than 35 were excluded. These are very rare, and the count across these age 
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groups by race/ethnicity and education included many zeroes, which prohibited the development 
of stable estimates for the mortality rate ratios. (Figure 2) 
 
Figure 2:  Decedents from CRC in CA included in analyses  
The number of deaths by distinct race/ethnicity are presented in Table 5. The largest groups 
among APIs were Chinese and Filipino, accounting for 31% and 23% of all API cases, 
respectively; Korean, Japanese and Vietnamese decedents each accounted for approximately 10-
12%. The vast majority of API decedents were foreign-born, over 93% in each subgroup except 
for Japanese and other APIs.  In contrast to the variation seen within APIs, Mexican decedents 
accounted for 82% of all Hispanic deaths in California; these were approximately equally split 
between Mexican Americans and Mexican Immigrants.  
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Table 5: Distribution and characteristics of CRC decedentsa in California, 2012-2017. 
Major Race/Ethnicity and 
Subgroup Deaths % Male % Foreign Bornb % age 50 or younger 
Non-Hispanic White 17,881 50% 13% 4% 
Non-Hispanic Black 2,507 50% 5% 7% 
Asian/Pacific Islander 3,981 51% 88% 8% 
     Chinese 1,224 53% 93% 7% 
     Filipino 907 51% 94% 9% 
     South Asian 162 59% 99% 12% 
     Vietnamese 410 54% 99% 12% 
     Korean 441 54% 99% 5% 
     Japanese 460 40% 38% 4% 
     Other API 377 51% 83% 0% 
Hispanicc 5,805 56% 57% 11% 
     Mexican American 2,407 57% 0% 11% 
     Mexican Immigrant 2,395 58% 100% 12% 
     Central American 511 45% 96% 16% 
     South American 257 47% 97% 5% 
     Puerto Rican 101 58% 60% 8% 
     Cuban 99 55% 94% 2% 
     Other Hispanic 35 59% 60% 8% 
TOTAL 30,174    
a. Excludes Native American and Other/Unknown race/ethnicity, unknown education, and ages less 
than 35. b. Birth in Puerto Rico considered foreign-born. c. Hispanic and Hispanic subgroup 
population and deaths based on proportional partition of Hispanic NOS (Not-Otherwise-Specified) 
Cases  
 
After examination of the distribution of total CRC deaths for each subgroup across 2 sexes, 3 
education levels, and 10 age groups (60 cells), many subgroups were eliminated from subgroup-
specific analyses due to sparse distribution (death counts of less than 5 in 20% of cells or more 
were considered too sparse to produce stable estimates). However, these subgroups were 
included in major group analyses. The groups remaining for analysis, as well as their distribution 
of deaths by educational level, are presented in Table 6.  Notably, Filipinos had the highest 
proportion of decedents with higher-level education, 51% of all cases, while Mexican Immigrant 
decedents had only 6% in the highest level, but 68% with less than a high school education. 
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Table 6: Distribution of educational level by race/ethnicity among CRC decedents in 
California, 2012-2017. 
Race/Ethnicity 
Less than 
 High School 
High School or 
equivalent 
Associate’s 
degree or higher Total Deaths 
Non-Hispanic White 9% 56% 35% 17,881 
Non-Hispanic Black 13% 60% 27% 2,507 
Asian/Pacific Islandera 20% 41% 40% 3,981 
Chinese 27% 36% 38% 1,224 
Filipino 11% 38% 51% 877 
Hispanica 46% 41% 13% 5,805 
Mexican American 29% 56% 15% 2,407 
Mexican Immigrant 68% 26% 6% 2,395 
a. Includes groups not listed separately 
 
4.1.2 Mortality Rate Ratios Stratified by Race/Ethnicity 
In all analyses stratified by race/ethnicity, the reference category was the highest level of 
education studied: those with at least an associate’s degree. Among NHWs, NHBs, APIs, and 
Hispanic males and females, those at the middle level of education, with only a high school 
education or equivalent, had higher CRC mortality than those with higher education. However, 
only among NHWs was this trend continued for the lowest level of education, less than high 
school. Among NHB men and women as well as Hispanic men, those with the lowest education 
had mortality not significantly different than those with the highest mortality. For API men and 
women as well as Hispanic women, the trend reversed as CRC mortality was significantly lower 
among those with the lowest education level compared to those with the highest (Table 7).  
Subgroup patterns revealed a few notable differences. Mexican American men had 59% and 32% 
higher CRC mortality among the middle and lowest education levels, respectively, compared to 
the highest. However, Mexican Immigrant men at the middle level of education had only 33% 
higher than the lowest level; there were no differences between the lowest and highest levels of 
education. Among Mexican American and Mexican Immigrant women, there were no 
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statistically significant differences in CRC mortality by educational level. Differences were also 
not found by educational level among Filipino men; numbers were too sparse for developing rate 
ratios for women. Chinese men and women at the middle level of education had 55% and 36% 
higher CRC mortality, respectively, than their counterparts in the highest education level. 
However, Chinese men with the lowest education level had 20% lower CRC mortality than those 
with the highest level; women at the lowest and highest educational level were not significantly 
different.     
Table 7: Age-adjusted CRC mortality risk by educational level* among distinct 
racial/ethnic groups in California, 2012-2017. 
MALE 
Associate's 
Degree or Higher 
High School or 
Equivalent 
Less than High School 
Major groups MRR (95% CI) MRR 95% CI MRR 95% CI 
Non-Hispanic White 1.00 1.45 (1.45-1.70) 1.40 (1.26-1.56) 
Non-Hispanic Black 1.00 1.33 (1.17-1.51) 0.98 (0.81-1.18) 
Asian/Pacific Islander 1.00 1.37 (1.32-1.42) 0.76 (0.73-0.80) 
Hispanic 1.00 1.40 (1.32-1.48) 1.03 (0.97-1.09) 
Subgroups 
     
Chinese 1.00 1.55 (1.30-1.85) 0.80 (0.65-0.99) 
Filipino 1.00 1.00 (0.82-1.21) 0.70 (0.49-1.01) 
Mexican American 1.00 1.59 (1.36-1.86) 1.32 (1.11-1.57) 
Mexican Immigrant 1.00 1.33 (1.05-1.70) 1.01 (0.81-1.28) 
FEMALE 
     
Major groups 
     
Non-Hispanic White 1.00 1.44 (1.32-1.57) 1.23 (1.10-1.38) 
Non-Hispanic Black 1.00 1.22 (1.07-1.38) 0.85 (0.70-1.03) 
Asian/Pacific Islander 1.00 1.32 (1.28-1.37) 0.90 (0.86-0.94) 
Hispanic 1.00 1.08 (1.03-1.13) 0.83 (0.80-0.87) 
Subgroups 
     
Chinese 1.00 1.36 (1.10-1.67) 0.98 (0.78-1.21) 
Filipino 1.00 0.93 (0.75-1.15) 0.71 (0.53-0.96) 
Mexican American 1.00 1.11 (0.92-1.32) 1.00 (0.82-1.22) 
Mexican Immigrant 1.00 0.99 (0.75-1.29) 0.88 (0.69-1.14) 
a. Individual negative binomial regression models adjusted for age group 
 
4.1.3 Mortality Rate Ratios Stratified by Educational Level 
In all analyses stratified by education level, the reference category was NHWs. Among 
Hispanics and APIs, risk of CRC mortality was significantly lower than NHWs at the lowest 
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educational level. For Hispanic men, mortality was similar to NHWs at both the high school and 
college levels; for women, mortality risk was lower at high school level but equivalent at highest 
educational level. API women had consistently lower CRC mortality than NHWS, but the effect 
size diminished as educational level increased. API men saw a similar effect, with convergence 
of risk with NHW men at the highest educational level (Table 8).   
Table 8: CRC mortality rate ratiosa (MRR) by major race/ethnicity, stratified by 
educational level, California 2012-2017. 
MALE Less than High School High School or Equivalent Associate’s degree or 
higher 
MRR 95% CI p-
value 
MRR 95% CI p-
value 
MR
R 
95% CI p-
value 
Non-Hispanic 
White 
reference reference reference 
Non-Hispanic 
Black 
1.06 (0.87-1.30) 0.55 1.36 (1.26-1.47) 0.00 1.64 (1.46-1.84) 0.00 
Hispanic 0.77 (0.68-0.88) 0.00 0.94 (0.88-1.01) 0.07 1.04 (0.93-1.16) 0.46 
Asian/Pacific 
Islander 
0.55 (0.51-0.60) 0.00 0.89 (0.85-0.92) 0.00 1.01 (0.95-1.08) 0.68 
FEMALE 
Non-Hispanic 
White 
reference reference reference 
Non-Hispanic 
Black 
1.03 (0.80-1.33) 0.81 1.36 (1.25-1.47) 0.00 1.65 (1.47-1.85) 0.00 
Hispanic 0.67 (0.61-0.73) 0.00 0.74 (0.71-0.77) 0.00 1.03 (0.95-1.11) 0.46 
Asian/Pacific 
Islander 
0.67 (0.62-0.72) 0.00 0.81 (0.78-0.84) 0.00 0.88 (0.83-0.94) 0.00 
a. Adjusted for age group 
 
Compared to NHWs, Filipino men had 17% higher CRC mortality and Filipino women were not 
significantly different than their NHW counterparts. However, at both the middle and lower 
educational levels, CRC mortality risk was lower among Filipino men and women that NHWs. 
For Chinese men, risk was lower in the low education group; however, there were no significant 
differences between them and the referent NHW groups in the high school and college groups. 
Chinese women had lower mortality risk across all levels of education, but the effect was 
strongest in the lowest educational level (Table 9).  
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Table 9: CRC mortality rate ratiosa (MRR) for Chinese and Filipinos compared to NHWs, 
stratified by educational level, California 2012-2017.     
MALE 
Less than High School High School or Equivalent Associate’s degree or higher 
MRR 95% CI p-value MRR 95% CI 
p-
value MRR 95% CI 
p-
value 
Non-Hispanic 
White reference reference reference 
Chinese 0.57 (0.48-0.69) 0.00 1.01 (0.89-1.16) 0.83 1.03 (0.92-1.17) 0.58 
Filipino 0.56 (0.40-0.78) 0.00 0.76 (0.66-0.88) 0.00 1.17 (1.01-1.37) 0.04 
FEMALE   
Non-Hispanic 
White reference reference reference 
Chinese 0.61 (0.44-0.85) 0.00 0.83 (0.72-0.95) 0.01 0.85 (0.72-0.99) 0.04 
Filipino 0.54 (0.39-0.76) 0.00 0.6 (0.50-0.70) 0.00 0.97 (0.85-1.11) 0.65 
a. Adjusted for age group 
 
Finally, patterns for Mexican Immigrants showed lowest CRC mortality risk for men and women 
at the lowest and middle educational level compared to NHWs, but the advantage no longer 
remained at the highest level; risk was not significantly different.  However, Mexican American 
men and women had CRC mortality risk that was not significantly different from NHWs at every 
educational level (Table 10).  
Table 10: CRC mortality risk ratiosa (MRR) for Mexican Americans and Mexican 
Immigrants, compared to NHWs, stratified by educational level, California 2012-2017.   
MALE 
Less than High School High School or Equivalent Associate’s degree or higher 
MR
R 95% CI 
p-
value 
MR
R 95% CI 
p-
value 
MR
R 95% CI 
p-
value 
Non-Hispanic 
White reference reference reference 
Mexican American 0.86 (0.72-1.03) 0.11 1.14 (0.92-1.42) 0.24 1.20 (0.98-1.46) 0.07 
Mexican 
Immigrant 0.63 (0.57-0.70) 0.00 0.77 (0.69-0.86) 0.00 0.96 (0.77-1.20) 0.74 
FEMALE   
Non-Hispanic 
White reference reference reference 
Mexican American 0.82 (0.63-1.07) 0.14 0.94 (0.73-1.20) 0.61 1.22 (0.96-1.55) 0.10 
Mexican 
Immigrant 0.57 (0.51-0.64) 0.00 0.61 (0.53-0.69) 0.00 0.91 (0.69-1.20) 0.50 
a. Adjusted for age group 
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4.2 Project 2: Colorectal Cancer Survival in Nevada 
4.2.1 Study Population 
In the 11-year period of 2003-2013, first primary colorectal cancer tumors were identified in 
12,413 patients from the Nevada Central Cancer Registry. 45% of patients were female, 39% 
were less than 65 years of age, 78% were non-Hispanic white and two-thirds were from Southern 
Nevada. Almost half were married; 73% had either private insurance or Medicare. Over 90% of 
tumors were some type of ADK; distribution between right colon, left colon, and rectum was 
approximately equal but almost 10% were colon NOS cases. 68% of tumors (n=8480) were 
diagnosed in AJCC Stages I, II, or III; of those, only 36% received Treatment According to 
Guidelines, while 39% did not. For 26% of CRC cases, TAG was unable to be determined due to 
missing treatment information. (Table 11).  
4.2.2 Overall Colorectal Cancer Survival by Race/Ethnicity 
Overall five-year age-adjusted colorectal-cancer-specific survival in Nevada was 56.0% (95% 
CI: 54.6-57.5) among males, significantly lower than females at 59.5% (95% CI: 58.0-61.1); 
both were significantly lower than corresponding national proportions of 65.1% and 66.5% based 
on the SEER-18 catchment area for the same time period. Within Nevada, non-Hispanic black 
males had the lowest survival of any group, at 48.3% (95% CI: 42.7-53.9), and Other API 
females had the highest at 68.8% (95% CI: 61.6-76.0). However, for every distinct male 
racial/ethnic group, CRC survival in Nevada was significantly lower than CRC survival of their 
counterparts nationally. Likewise, non-Hispanic white and Hispanic females had significantly 
lower survival compared to SEER-18 CRC patients of the same race/ethnicity (Table 12). 
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Table 11: Characteristics of 12,413 CRC cases in Nevada, 2003-2013. 
DEMOGRAPHIC FACTORS N % 
Sex Male 6,817 54.9 
Female 5,596 45.1 
Age Group 16-44 years old 583 4.7 
45-54 years old 1,519 12.2 
55-64 years old 2,730 22.0 
65-74 years old 3,589 28.9 
75+ years 3,992 32.2 
Race/Ethnicity Non-Hispanic white 9,674 77.9 
Non-Hispanic black 927 7.5 
Hispanic 1,041 8.4 
Filipino 220 1.8 
Other Asian/Pacific Islander 467 3.8 
American Indian/Alaskan Native 84 0.7 
Nevada Region Northwestern Nevada 2,714 21.9 
Southern Nevada 8223 66.2 
Rural Nevada 1,025 8.3 
Unknown 451 3.6 
SOCIAL FACTORS    
Marital Status Married 6,008 48.4 
Single 1,887 15.2 
Divorced/Separated 1,284 10.3 
Widowed 1,899 15.3 
Unknown 1,335 10.8 
Insurance Status Private Insurance 4,470 36.0 
Medicare 4,579 36.9 
Medicaid 602 4.8 
Uninsured 470 3.8 
Unknown 2,292 18.5 
Socioeconomic Status High 2,453 19.8 
Intermediate 4,222 34.0 
Low 4,878 39.3 
Unknown 860 6.9 
CLINICAL FACTORS    
Stage at Diagnosis AJCC I 2,429 19.6 
AJCC II 2,798 22.5 
AJCC III 3,253 26.2 
AJCC IV 2,097 16.9 
Unknown 1,836 14.8 
Morphology Adenocarcinoma (ADK) 9,614 77.5 
ADK in adenoma/polyp 481 3.9 
Mucinous ADK 1,173 9.4 
Carcinoids 307 2.5 
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Carcinoma NOS 838 6.8 
Sublocation of Tumor Colon-Right 3,902 31.4 
Colon-Left 3,767 30.3 
Rectum  3,588 28.9 
Colon NOS 1,156 9.3 
TREATMENT ACCORDING TO GUIDELINESa n=8,480   % 
Received  Yes 3,028 35.7 
No 3,263 38.5 
Unknownb 2,189 25.8 
Abbreviations: AJCC, American Joint Committee on Cancer; ADK, Adenocarcinoma; NOS, Not Otherwise 
Specified.a. Restricted to AJCC Stages I,II,III; b. Unable to make determination. 
 
Table 12: Five-year age-adjusteda all-stages-combined CRC survival by sex and by 
race/ethnicityb. Nevada compared to overall United Statesc, 2003-2013. 
 Nevada Overall US 
MALE Survival 95% CI Survival 95% CI 
All Race/ethnicities 56.0% (54.6-57.5) 65.1% (64.8-65.3) 
Non-Hispanic white 59.3% (57.7-61.0) 65.9% (65.6-66.2) 
Non-Hispanic black 48.3% (42.7-53.9) 56.0% (55.0-56.9) 
Hispanic 57.0% (51.9-62.1) 64.3% (63.4-65.1) 
Filipino 46.1% (34.2-58.0) 67.7% (65.5-69.7) 
Other API 59.8% (52.1-67.6) 69.3% (68.2-70.3) 
FEMALE 
All Race/ethnicities 59.5% (58.0-61.1) 66.5% (66.3-66.8) 
Non-Hispanic white 59.9% (58.1-61.6) 67.2% (66.9-67.5) 
Non-Hispanic black 54.3% (48.6-60.1) 60.3% (59.5-61.1) 
Hispanic 56.0% (50.7-61.4) 66.6% (65.6-67.4) 
Filipino 63.2% (52.9-73.5) 69.6% (67.4-71.6) 
Other API 68.8% (61.6-76.0) 70.0% (68.9-71.0) 
Abbreviations: API, Asian/Pacific Islander; CI, Confidence Interval; US, United States. 
a. Adjusted according to International Cancer Survival Standard. b. American Indian/Alaskan Native suppressed 
due to small numbers c. SEER-18. 
 
4.2.3 Survival by Stage at Diagnosis by Region of Nevada 
Examining by stage at diagnosis, five-year CRC survival in the entire state of Nevada for 
localized and regional stage tumors was significantly lower than national survival. Males and 
females in Nevada diagnosed with CRC at a localized stage had 5-year survival proportions of 
83.3% and 86.7%, respectively, compared to national survival of 88.6% (males) and 90.0% 
(females). Even larger survival differences were seen for males and females in Nevada diagnosed 
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with CRC at a regional stage; 5-year survival was 61.9% and 63.2%, respectively, compared to 
national survival of 69.9% (males) and 71.4% (females). Survival for distant stage CRC tumors 
was not significantly different than national survival for either sex. Notably, by geographic 
region of Nevada, stage-specific survival in Northwestern Nevada did not differ from national 
survival at any stage for both men and women. Five-year CRC survival in Southern Nevada was 
significantly lower than national survival for all diagnosis stages except for distant stage in men. 
(Table 13).    
4.2.4 Determinants of Colorectal Cancer Death 
Even after full-adjustment for all clinical, social, and demographic covariates significant in 
univariate analysis, Cox proportional hazard model estimates indicated that female CRC patients 
were at 11% lower risk of death than male. Southern Nevadans were at 17% higher risk than 
their counterparts in Northwestern Nevada (HR: 1.17; 95% CI: 1.08-1.27). By race/ethnicity, 
non-Hispanic blacks and Filipinos did not differ significantly from non-Hispanic whites, while 
Hispanics and Other APIs had 14% and 25% significantly lower risk, respectively (HR: 0.86; 
95% CI: 0.77-0.97) and (HR: 0.75; 95% CI: 0.63-0.90). Patients with any insurance status type 
other than private insurance had higher risk of CRC death. Likewise, any marital status besides 
the referent, married, conferred significantly higher risk of death. CRC mortality risk increased 
inversely with socioeconomic status. For clinical factors, carcinoma NOS cases had 74% higher 
risk than the referent ADK morphology. By tumor sublocation, patients with colon NOS cases 
had an almost 50% higher risk of death than those with right-sided tumors, while risk of death 
from a left-sided CRC tumor was lower than from a right-sided tumor (HR: 0.89; 95% CI: 0.82-
0.97). Patients with metastatic CRC, AJCC stage IV, had a 14 times higher risk of death than 
those with Stage I. (Table 14). 
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Table 13: Five-year age-adjusteda all-stage & stage-specific CRC survival by geographic region of Nevada compared to overall 
United Statesb, 2003-2013. 
 All Stages Localized Stage Regional Stage Distant Stage 
MALE Survival 95% CI Survival 95% CI Survival 95% CI Survival 95% CI 
Overall United Statesb 65.1% (64.8-65.3) 88.6% (88.3-88.8) 69.9% (69.4-70.4) 13.0% (12.5-13.4) 
Nevada 56.0% (54.6-57.5) 83.3% (81.3-85.3) 61.9% (59.6-64.2) 11.8% (9.5-14.0) 
Northwestern NV 58.8% (55.7-61.9) 85.2% (81.2-89.3) 64.8% (60.0-69.6) 15.2% (10.1-20.2) 
Southern Nevada 55.8% (54.0-57.5) 82.3% (79.8-84.8) 61.8% (58.9-64.6) 10.2% (7.5-12.9) 
Rural Nevadac 52.2% (47.0-57.4) - - - - - - 
FEMALE  
Overall United Statesb 66.5% (66.3-66.8) 90.0% (89.7-90.3) 71.4% (71.0-71.8) 15.2% (14.7-15.7) 
Nevada 59.5% (58.0-61.1) 86.7% (84.5-88.8) 63.2% (60.8-65.7) 14.0% (11.3-16.7) 
Northwestern NV 63.8% (60.6-67.0) 89.1% (85.1-93.1) 66.4% (61.3-71.6) 21.3% (15.0-27.7) 
Southern Nevada 58.3% (56.4-60.2) 85.9% (83.3-88.6) 62.0% (59.0-65.0) 10.5% (7.4-13.5) 
Rural Nevadac 58.4% (52.6-64.3) - - - - - - 
a. Adjusted according to International Cancer Survival Standard. b. SEER-18. c. Rural data were too sparse to accurately calculate age-adjusted survival by 
stage. 
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Table 14: Demographic, social, and clinical determinants of CRC risk of deatha in Nevada, 
2003-2013. 
Factors HR 95% CI 
Sex Male referent 
Female .89 (0.83-0.95) 
Nevada Region Northwestern Nevada referent 
Southern Nevada 1.17 (1.08-1.27) 
Rural Nevada 1.11 (0.98-1.27) 
Race/ Ethnicityb Non-Hispanic white referent 
Non-Hispanic black 0.96 (0.86-1.09) 
Hispanic 0.86 (0.77-0.97) 
Filipino 0.92 (0.74-1.16) 
Other Asian/Pacific Islander 0.75 (0.63-0.90) 
Marital Status Married referent 
Single 1.14 (1.04-1.25) 
Divorced/Separated 1.26 (1.14-1.40) 
Widowed 1.27 (1.15-1.40) 
Insurance Status Private Insurance referent 
Medicare 1.16 (1.07-1.27) 
Medicaid 1.38 (1.20-1.59) 
Uninsured 1.43 (1.24-1.66) 
Socioeconomic Status High referent 
Intermediate 1.22 (1.11-1.34) 
Low 1.38 (1.26-1.52) 
Stage at Diagnosis AJCC I referent 
AJCC II 1.93 (1.67-2.24) 
AJCC III 3.48 (3.03-3.99) 
AJCC IV 14.44 (12.60-16.55) 
Unknown 4.94 (4.23-5.76) 
Morphology Adenocarcinoma (ADK) referent 
ADK in adenoma/polyp 0.73 (0.57-0.92) 
Mucinous ADK 1.06 (0.95-1.17) 
Carcinoids 0.42 (0.31-0.57) 
Carcinoma NOS 1.74 (1.53-1.99) 
Sublocation of Tumor Colon-Right referent 
Colon-Left 0.89 (0.82-0.97) 
Rectum 0.98 (0.91-1.07) 
Colon NOS 1.47 (1.31-1.65) 
Abbreviations: ADK, Adenocarcinoma; AJCC, American Joint Committee on Cancer; CI, Confidence Interval; HR, 
Hazard Ratio; NOS, Not Otherwise Specified. 
a. Multivariate Cox Proportional Hazards: Adjusted for all variables shown as well as age group and year of 
diagnosis. b. American Indian/Alaskan Native suppressed due to small numbers. 
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4.2.5 Receipt of Treatment According to Guidelines 
Restricting analysis to Nevada’s CRC cases diagnosed in AJCC stages I-III and adjusting for 
age, sex, race/ethnicity, and year of diagnosis, patients who were identified as not receiving TAG 
had 2.47 times the risk of death (95% CI: 2.21-2.76) within 5 years. Moreover, death from CRC 
at these stages after adjustment for TAG was 14% and 28% significantly higher in Southern and 
Rural Nevada, (HR: 1.14; 95% CI: 1.01-1.29) and (HR: 1.28; 95% CI: 1.03-1.58), respectively, 
than in the Northwestern region. (Table 15).  
Table 15: Risk of deatha from CRC, restricted to AJCC stage I-III tumors with known 
TAG status, by geographic region and TAG, Nevada, 2003-2013.  
Model 1b Model 2c 
HR 95% CI HR 95% CI 
Nevada Region 
Northwestern Nevada referent referent 
Southern Nevada 1.20 (1.06-1.36) 1.14 (1.01-1.29) 
Rural Nevada 1.37 (1.11-1.69) 1.28 (1.03-1.58) 
Treatment According to Guidelines 
Received TAG 
  
referent 
Did not receive TAG - - 2.47 (2.21-2.76) 
Abbreviations: AJCC, American Joint Committee on Cancer; CI, Confidence Interval; HR, Hazard ratio; TAG, 
Treatment According to Guidelines. 
a. Multivariate Cox Proportional Hazards b. Model 1 adjusted for sex, age group, race/ethnicity, and year of 
diagnosis. c. Model 2 adjusted for all Model 1 variables and TAG. 
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Chapter 5. Discussion 
5.1 Project 1: Colorectal Cancer Mortality and Education 
Approximately 5,200 people died each year from CRC in California during our study period, 
2012-2017. While CRC mortality has been decreasing over time, the gains are not distributed 
evenly, resulting in disparities, or potentially avoidable differences (Siegel et al., 2017). In the 
current study, we examined CRC deaths for all males and females of the four major 
race/ethnicity groups as well as four specific subgroups usually presented as part of aggregated 
groups, including Chinese and Filipinos, who number almost five and four million, respectively, 
in the US, as well as Mexican Americans (US-born), 24 million, and Mexican Immigrants, 
almost 12 million (Ruggles et al.).  
Our first aim was to examine variation by race/ethnicity in the association between education and 
CRC mortality. For all major race/ethnicity major groups, CRC mortality was highest at the 
middle level of education. Subgroups also showed this pattern except for Filipino men, Filipino 
women, and Mexican Immigrant women, who had highest CRC mortality in the most educated 
group. No population showed highest CRC mortality in the lowest educated group.  
Our second aim was to examine the variation by education level in the association between 
race/ethnicity and CRC mortality. By major racial/ethnic group, we found that for Hispanic and 
API men and women at the lowest level of education, mortality was lower than NHWs. 
However, at the highest level of education, Hispanic men and women as well as API men had 
mortality not significantly different than NHWs. Examination of subgroups showed a more 
complex picture, with notable variation by sex. Mexican American men and women and Filipino 
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men at the highest level of education had CRC mortality exceeding NHWs by approximately 
20%, (although not statistically significant for Mexican Americans).  
5.1.1 Aim 1: Variation by Race/Ethnicity in the Association between Education and 
Colorectal Cancer Mortality  
Among NHW, NHB, API, and Hispanic women and men, CRC mortality was uniformly highest 
among decedents at the middle level of education rather than the lowest level. Explaining these 
findings conclusively would require information that we do not have, CRC survival and CRC 
incidence of each distinct population by educational level, since these past CRC incidence and 
survival trends combined to produce the observed CRC mortality in the current study. For any 
given race/ethnicity group, the higher mortality seen at the middle level could indicate higher 
incidence and/or lower survival compared to their counterparts, whether the less educated or 
more educated group.  
Comparing just the lowest level of education with the highest, by major race/ethnicity group, 
only NHW men and women had higher CRC mortality at the lowest level of education than the 
highest. Mortality was not significantly different at the highest and lowest educational level for 
NHB men and women and Hispanic men. For Hispanic women and API men and women, CRC 
mortality was lower at the lowest educational level than the highest. By subgroup, only Mexican 
American men had higher CRC mortality at the lowest level of education than the highest. 
Remarkably, despite lower rates in the aggregated API subgroup, we found that only Chinese 
men and Filipino women had mortality risk that was lower at the lowest educational level than 
their counterparts with the highest level of education; all other analyzed subgroups had mortality 
approximately equivalent at the lowest and highest educational levels. Except for Mexican 
Americans, these subgroups are predominantly, (or entirely), comprised of immigrants, born in 
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China, the Philippines, or Mexico. Theoretically, this pattern for all immigrant subgroups could 
reflect equivalent CRC risk between the two groups, (most and least educated), and equivalent, 
or better, survival. However, equivalent or better survival in the lowest level of education for 
immigrant groups is highly unlikely for several reasons. 
Survival from CRC is closely linked to stage at diagnosis; a more favorable stage distribution for 
any given group leads to better survival proportions (Lai et al., 2016; White, Joseph, et al., 
2017). Furthermore, stage distribution is linked to CRC screening, which has the potential to 
detect tumors at earlier stages with a more favorable prognosis (Lee, 2006; Meester et al., 2015). 
Compared to other states, California has a relatively high overall proportion of CRC screening, at 
nearly 71% (Joseph, King, Richards, Thomas, & Richardson, 2018). As an early Medicaid 
expansion state, California saw increases in screening among low-income populations compared 
to non-expansion states (Zerhouni et al., 2019). Nonetheless, across the US, screening is lower 
among APIs and Hispanics than NHW and NHB groups; immigrants also have low screening 
prevalence (Afable-Munsuz, Liang, Ponce, & Walsh, 2009; Goel et al., 2003; Gorin & Heck, 
2005; Gwede et al., 2010; Johnson-Kozlow, 2010; Savas, Vernon, Atkinson, & Fernandez, 2015; 
Seay et al., 2015; Zambrana, Breen, Fox, & Gutierrez-Mohamed, 1999). Notably, Mexican 
Immigrants have extremely low CRC screening prevalence, at just 36% of all eligible adults 
(Hall et al., 2018; Joseph et al., 2018). Therefore, the expansion of Medicaid may not have 
improved screening compliance for Mexican Immigrants or other immigrants, who are less likely 
to have and/or qualify for insurance coverage (Kaizer Family Foundation, 2019). Additionally, a 
few recent studies examined CRC screening prevalence by educational level, without specifying 
a particular race/ethnicity, and found that those with less than high school education had the 
 47 
 
lowest compliance with recommended CRC screening, only 47% compared to 71% compliance 
among those with graduate degrees. (Hall et al., 2018; White, Thompson, et al., 2017).  
Survival from a CRC diagnosis is also linked to treatment received and whether it is appropriate 
and timely (Aarts, Lemmens, Louwman, Kunst, & Coebergh, 2010; Frederiksen, Osler, Harling, 
Ladelund, & Jørgensen, 2009; Haas et al., 2011; Lai et al., 2016; Le et al., 2008; Morris et al., 
2008; White et al., 2010). In turn, treatment is linked to insurance status (Dominitz et al., 1998; 
Roetzheim et al., 2000). Often, people with lower levels of education who are not qualified for 
Medicare are either Medicaid-insured or not insurance (Berchick, Hood, & Barnett, 2018); these 
groups have worse cancer outcomes than those with private insurance (Abdelsattar, Hendren, & 
Wong, 2017; Amini et al., 2016; Parikh-Patel, Morris, & Kizer, 2017). In particular, CRC 
patients who are uninsured or on Medicaid have been shown to have lower odds of tumor 
resection (Loehrer et al., 2016). Further, a recent study conducted in California found that CRC 
patients with Medicaid or dual Medicaid/Medicare had lower likelihood of receiving adjuvant 
chemotherapy after resection for Stage III tumors (Parikh-Patel et al., 2017).   
Thus, given the known predictors of poor CRC survival, it is highly unlikely that our findings 
reflect a pattern of better survival among immigrants with low education. Thus, the explanation 
for equivalent or lower CRC mortality found among these primarily immigrant groups must lie 
in lower incident cases among the lower education group, and conversely, those with higher 
education have higher incidence.  
To our knowledge, CRC incidence has not been assessed for distinct population groups by 
educational level, but it is plausible that those with lower education have fewer risk factors for 
CRC. Employment options for those without a high school degree may be restricted to jobs 
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requiring greater physical activity, such as agriculture, landscaping, construction, housekeeping, 
service jobs, etc. (Berkman et al., 2014; McCauley, 2005) Employment in highly physical 
occupations is also likely linked to maintenance of a healthier weight (Gallegos-Carrillo, 
Belcher, Dunton, Samet, & Baezconde-Garbanati, 2018). As both physical activity and healthy 
weight are protective against CRC (Chan & Giovannucci, 2010; Dai, Xu, & Niu, 2007; Doubeni 
et al., 2012; Huxley et al., 2009), this may partially explain the advantage seen in lower educated 
groups, especially immigrant. Furthermore, diet quality, including overconsumption of fats, 
sugars, and processed meats and underconsumption of high-fiber foods including fruits and 
vegetables are linked to CRC incidence (Aune, Chan, et al., 2011; Aune, Lau, et al., 2011; 
Bouvard et al., 2015; Chan & Giovannucci, 2010; Chan et al., 2011; Cho et al., 2004; Huxley et 
al., 2009). Previous research has shown that the traditional diets of immigrants are healthier than 
the standard American diet, and that over time, immigrants experience negative acculturation and 
adopt less healthy eating habits (Akresh, 2007; Ayala, Baquero, & Klinger, 2008; Bolstad & 
Bungum, 2013; Murillo, Albrecht, Daviglus, & Kershaw, 2015; Oladele et al., 2018; Sharkey, 
Johnson, & Dean, 2011; Vargas & Jurado, 2015). It is plausible, although we were unable to find 
supporting evidence, that immigrants at lower educational levels maintain their traditional 
healthier diets for a longer duration than immigrants at higher educational levels, which may also 
contribute to the relatively lower CRC incidence suggested in the current study. Thus, from a 
public health standpoint, it is worthy to further explore and confirm low incidence among the 
lowest educated of these populous immigrant groups, Mexican Immigrants, Filipinos, and 
Chinese, and intercede to stem the increases in risk associated with acculturation. From the 
opposite perspective, CRC risk appears higher among those who are well-educated; targeted and 
community-based CRC prevention interventions are warranted.  
 49 
 
Our findings were somewhat discordant with previous research. We hypothesized that lower 
education would be associated with higher CRC mortality, as is common for many health 
outcomes. Previous research, both with individual level education data (Albano et al., 2007; 
Jemal et al., 2015) and with county-level ecological education indicators (Weir et al., 2017), 
documented that those at the lowest educational level had higher CRC mortality than those at the 
highest level for NHWs and NHBs; if included, results for Hispanics were inconsistent (Siegel et 
al., 2011). Our study was not able to replicate these findings, except among NHW men and 
women. Even then, the CRC mortality risk was highest at the middle level of education, not the 
lowest level.  
Several study design differences may explain our differing results. First, all previous US studies 
assessing the association between individual-level education and mortality chose to include only 
decedents ages 25-65 in their analyses (Albano et al., 2007; Jemal et al., 2015; Kinsey et al., 
2008; Siegel et al., 2011); authors cited research suggesting that education is a better index of 
SES in these age groups than at older ages (Jemal, Simard, Xu, Ma, & Anderson, 2013). 
However, since the majority of tumors occurred in ages older than 65, and we wanted to include 
as many tumors as possible, we decided to do our analyses with CRC patients ages 35 and above. 
Secondly, these previous researchers used direct rate ratios of mortality rates that had been age-
adjusted to the standard US 2000 population. Conversely, we used age-specific rates in a 
regression model to develop MRRs because we felt this would better capture actual rate 
relationships, avoiding the adjustment with a population standard that does not reflect the 
underlying population structure of Asian and Hispanics (Kim & Kriebel, 2009), never thoroughly 
studied in relation to education and thus the focus of our study.  
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5.1.2 Aim 2: Variation by Educational Level in the Association between Race/Ethnicity 
and Colorectal Cancer Mortality  
Racial/ethnic patterns in CRC mortality varied when analyzed separately at each educational 
stratum. NHBs in CA had equivalent mortality to NHWs at the lowest educational level and 
higher CRC mortality at the middle educational level; the greatest disparity between NHBs and 
NHWS was seen at the highest level of education. Similarly, the most reduced CRC mortality 
among Hispanics and APIs compared to NHWS was at the lowest educational level; non-
Hispanic men and women and API men had equivalent risk at the highest educational levels; 
only API women retained lower risk than NHWS at the highest educational level. Thus, we 
found that for those with a college degree or more, well-established race/ethnicity cancer patterns 
showing NHBs with the highest CRC mortality, followed by NHWs, Hispanics, and APIs (Siegel 
et al., 2018) did not hold. As mentioned previously, truly understanding what drives these 
patterns would require detailed knowledge of CRC incidence and survival by race/ethnicity at 
each educational level, which is largely lacking in the literature.  
Similar patterns were evident for subgroups. Prior studies showed lower CRC mortality for 
Mexican Immigrant men and women than NHWs (Pinheiro, Callahan, Gomez, et al., 2017); 
however, stratification by educational level shows this effect is only evident in the two lower 
educational levels, indicating nuances to previously documented CRC patterns for subgroups 
when stratifying by educational level. Mexican Immigrant men and women with college degrees 
were not significantly different in CRC mortality than their NHW counterparts. Likewise, 
Chinese and Filipinos only showed lower CRC mortality than NHWs at the lowest and middle 
educational level, but not at the highest. The significant excess CRC mortality experienced by 
Filipino men compared to NHW men at the highest educational level was remarkable, a disparity 
only evident because of disaggregation by educational level.  
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Without detailed knowledge of past incidence and survival trends by subgroup for each 
educational level, we can only speculate based on what has been shown in the literature. The 
health benefits typically associated with higher educational include access to insurance, tumors 
diagnosed in early stages, and receipt of timely and appropriate treatment (Berchick et al., 2018; 
Goldman & Smith, 2011; Kimbro, Bzostek, Goldman, & Rodriguez, 2008; Jennifer Karas 
Montez & Friedman, 2015; Zimmerman et al., 2015). For NHWs, those benefits are reflected in 
the race-specific pattern of lower CRC mortality among the most highly educated group seen in 
the current study. However, our findings suggest that these benefits, which typically translate 
into better survival, may not be shared by minority populations in the US.  
The burden of CRC incidence is also important. For NHWs, the lower CRC mortality seen 
among those with higher education may reflect lower incidence, due to lower prevalence of CRC 
risk factors (He & Baker, 2005; Tavani et al., 1999). Conversely, our findings suggest an 
increase in CRC incidence among the most highly educated minority groups, especially 
immigrants, likely due to an increase in CRC risk factors. In particular, Filipino men have been 
previously documented to have CRC incidence equivalent to NHW men (Jin et al., 2016). 
However, their increased CRC mortality than NHWs at the highest educational level suggests 
that not only is CRC risk increased for Filipino men, but survival may be decreased. The lower 
survival suggested here for Filipino men is concordant with one relatively older study which 
found comparatively low CRC survival among Filipinos in California (Lin et al., 2002). 
Nonetheless, this low survival contrasts with national studies showing the highest CRC survival 
by race/ethnicity among APIs in aggregate (American Cancer Society, 2017), which further 
confirms the importance of disaggregating racial/ethnic groups whenever possible in order to 
develop a comprehensive portrait of disparities.   
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5.1.3 Strengths and Limitations 
The current study characterizes for the first time the association between educational level and 
mortality for distinct disaggregated sizable minority population groups in the US, on a 
population basis using individual-level data. Additionally, it is the first study to examine 
educational level and CRC mortality for Asian/Pacific Islanders in aggregate, previously 
excluded from analyses.  
Death certificate data has been found to be highly accurate for classification of CRC tumors; 
matching with registry data found over 94% conformation and detection rates (German et al., 
2011). Additionally, studies have found validity high validity of race and Hispanic origin on 
death certificates (Arias, Schauman, Eschbach, Sorlie, & Backlund, 2008) as well as birthplace 
for Hispanics and Asians (Gomez & Glaser, 2004). While there are some concerns with the 
validity of educational level on death certificates (Rostron, Boies, & Arias, 2010), with a 
tendency for overestimation, we have no reason to believe this would differ by race/ethnicity. 
Our categorization of education was based on research showing that the credential, rather than 
number of years, confers the health benefits associated with education (Lawrence, Rogers, & 
Zajacova, 2016; Montez, Hummer, & Hayward, 2012; Rogers, Everett, Zajacova, & Hummer, 
2010). However, it is possible that a different categorization could have yielded different results 
(Zimmerman et al., 2015).  
Our study was limited to the variables available from death certificates. Individual-level risk 
factors, comorbidities, screening and treatment history, all highly correlated with CRC outcomes, 
were not available. Lastly, it is possible that some foreign-born patients leave the US to die, an 
effect called the Salmon Bias, resulting in slightly underestimated mortality for immigrant 
groups in comparison to US-born (Abraido-Lanza, Dohrenwend, Ng-Mak, & Turner, 1999).    
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5.1.4 Conclusions 
In conclusion, our findings suggest that the association between educational level and CRC 
mortality is nuanced and complex. We speculate that CRC incidence may be rising for 
immigrant groups that are well-educated; this should be corroborated by examining CRC 
incidence patterns by educational level. It is also likely that the survival advantages attributable 
to higher education may be limited to US-born groups; this, too, should be confirmed so that 
developers of targeted and culturally-specific community-based interventions can rely on this 
information to prioritize their CRC planning needs. The mechanisms by which educational level 
confers benefits to specific groups are unknown, but likely include higher CRC screening uptake, 
lower prevalence of CRC risk factors, better access to care, and receipt of treatment according to 
guidelines. Interventions aimed at increasing these for all groups, irrespective of educational 
status, are critical to minimizing disparities and reducing the CRC mortality burden overall.  
5.2 Project 2: Colorectal Cancer Survival in Nevada 
Colorectal cancer is comparatively common yet typically less fatal than many other cancers; 
almost 1.5 million Americans in 2016 were CRC survivors (Miller et al., 2016). Yet in the 
Mountain West state of Nevada, the proportion of patients diagnosed with CRC that survived at 
least five years was much lower than the SEER-18 national survival (Howlader et al., 2018). In 
fact, based on a recent study of CRC survival in 38 US states (Nevada not included) (White, 
Joseph, et al., 2017), our data suggest that, despite slight methodological differences, survival 
from colorectal cancer in Nevada may be the lowest in the entire US. Such a striking disparity by 
state within one nation is unjust and merits immediate action: All Americans deserve equal 
opportunity for optimum health outcomes in the face of a cancer diagnosis. Thus, the current 
study provides baseline information critical to clinicians, public health professionals, and all 
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relevant stakeholders as they attempt to discern why Nevada’s outcomes are vastly divergent 
from its neighboring Western states and make plans for remediation.  
5.2.1 Geographic Disparity in Colorectal Cancer Survival 
The low CRC survival observed in populous Southern Nevada is driving the state’s 
overall poor survival profile. Unfortunately, similarly low survival has previously been 
documented in Nevada for breast cancer (Callahan et al., 2017) and lung cancer (Osuoha et al., 
2018). Taken alone, CRC survival in Northwestern Nevada is on par with national CRC survival. 
Nevada’s regional disparity is likely related to shortages of medical training centers and 
physicians, especially in the densely-populated Southern Nevada. Until the recent opening of the 
University of Nevada Las Vegas School of Medicine in Fall 2017, Southern Nevada was the 
largest metropolitan area in the US without a public medical school (Las Vegas Chamber of 
Commerce, 2015). It also ranked 46th in the nation for rates of residency and fellowship 
placements (Association of American Medical Colleges, 2017). Despite a 10% increase in 
physician-per-capita rate from 2005-2015 (Griswold, Gunawan, & Packham, 2018), Nevada 
ranked 48th - 49th of all US states for rates of active patient care physicians, active general 
surgeons and active primary care physicians per capita in 2015 (Association of American 
Medical Colleges, 2017). However, physician-per-capita rates in Northwestern Nevada were 
33% higher than in Southern Nevada (Griswold et al., 2018). Additionally, while Southern 
Nevada comprises approximately 73% of Nevada’s total population (United States Census 
Bureau, 2018), it had only 53% of its radiation oncologists, 65% of its gastroenterologists, and 
66% of its primary care physicians in 2015, which may have limited access to screening and 
treatment (Griswold et al., 2018). Efforts to recruit, train and retain medical professionals are 
urgently needed for Southern Nevada. 
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Particularly troubling from a clinical perspective was our finding that a significant 
portion of Nevadans with colorectal cancer did not receive treatment according to guidelines, 
especially in Southern and Rural Nevada. Previous US studies have linked racial/ethnic 
minorities, lack of insurance, and low socioeconomic status to lower likelihood of receiving 
recommended cancer TAG (American Cancer Society Cancer Action Network, 2018). In 
Nevada, future research should clarify the reasons why some patients in Nevada are not 
receiving TAG. Reasons are likely complex and multi-faceted, including access to care, practice 
differences between physicians, patient amenability to treatment based on age and comorbidities, 
and personal patient choices. If needed, modifications should be implemented to colorectal 
cancer care protocols by clinicians. Interventions should be developed to reduce barriers to 
receipt of TAG. Likewise, completeness and quality of cancer reporting, especially on treatment 
variables, should be improved to facilitate a more comprehensive picture of Nevada’s CRC 
profile.   
5.2.2 Other Determinants of Colorectal Cancer Survival 
Colon cancer screening on a population basis is one modifiable factor that has the 
potential to improve the distribution of stage at diagnosis, which is the single greatest predictor 
of CRC survival. CRC screening can detect tumors at earlier stages, leading to better survival 
outcomes (American Cancer Society, 2017). Screening can also prevent malignancies through 
the detection and removal of pre-cancerous polyps (American Cancer Society, 2017). In Nevada, 
prevalence of CRC screening compliance for 2002-2010 was just 58%, ranking 45th out of 50 
states, and well below the national CRC screening prevalence at that time of 65% (Centers for 
Disease Control and Prevention, 2011). Moreover, and likely contributing to the within-state 
survival disparities seen here, CRC screening uptake differs between the geographic regions of 
Nevada. BRFFS estimates show that, similar to national trends, CRC screening in the Reno 
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Metropolitan Statistical Area, (approximating Northwestern Nevada), increased from 49% in 
2002 to 69% in 2012. However, the Las Vegas Metropolitan Statistical Area, (approximating 
Southern Nevada), only increased from 46% to 59% (Centers for Disease Control and 
Prevention, 2016).  Additional resources should be committed to the development and 
implementation of CRC screening programs to increase uptake in Southern Nevada. 
Racial/ethnic minorities represented 28% of all Southern Nevada CRC cases; between 
80-90% of each minority population (except AI/AN) resided in Southern Nevada. Our finding of 
a lack of racial disparity in Nevada for adjusted risk of death between non-Hispanic blacks, 
Filipinos, and Hispanics compared to non-Hispanic whites runs counter to most other studies 
conducted in the US (Clegg, Li, Hankey, Chu, & Edwards, 2002; Du et al., 2007; Jones et al., 
2018; White et al., 2010). Yet, given that all racial/ethnic groups in Nevada had lower CRC 
survival than their national counterparts, this likely reflects the poor survival of the referent 
white group rather than highlighting any notable progress in eliminating disparities for 
minorities. A similar absence of black-white survival disparities was previously documented for 
both cervical cancer (El Ibrahimi & Pinheiro, 2015) and lung cancer in Nevada (Osuoha et al., 
2018). In the current study, Filipino men in Nevada had the largest survival gap, over 22 
percentage points different than Filipino men nationally. Importantly, while other studies have 
consistently documented better CRC survival for the aggregated Asian/Pacific Islander group 
compared to non-Hispanic whites (Doubeni et al., 2007; Siegel et al., 2017), our disaggregation 
of Filipinos as distinct from Other APIs revealed that only non-Filipino APIs had a survival 
advantage. Similarly, a previous study in California among distinct Asian groups found that 
Filipinos had significantly lower CRC survival than Chinese, Japanese, and non-Hispanic whites 
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(Lin et al., 2002). Thus, Filipinos, especially those in Southern Nevada, may benefit from 
targeted and culturally-specific CRC prevention programs, including colon cancer screening.  
Other factors impacting CRC survival in Nevada were consistent with the literature. 
Researchers have proposed several explanations for the survival advantage (Cook, McGlynn, 
Devesa, Freedman, & Anderson, 2011; Ellison, 2016; Micheli et al., 2009) of women for most 
cancers include sex-specific differences in risk factor prevalence, comorbidities and/or health 
seeking behaviors (Cook et al., 2011; Ellison, 2016) as well as sex hormones (Majek et al., 
2013). Not surprisingly, and consistent with previous research (Aarts et al., 2010; Byers et al., 
2008; Siegel et al., 2011; Singh & Jemal, 2017), a dose-response relationship was seen between 
patient SES status - previously linked to access to quality medical care, less aggressive treatment 
and delays in treatment (Doubeni et al., 2012; Steinbrecher et al., 2012) - and CRC survival in 
the current study. Married patients in the US have greater survival than single, separated, or 
widowed (Aizer et al., 2013; Kravdal, 2001; Osborne, Ostir, Du, Peek, & Goodwin, 2005), often 
linked to greater social support, financial benefits and better health insurance (Bernstein, Cohen, 
Brett, & Bush, 2008; Ell, Nishimoto, Mediansky, Mantell, & Hamovitch, 1992). Lastly, one 
clinical factor that conferred better CRC survival was tumor location on the left side of the colon, 
also previously documented (Benedix et al., 2010; Brenner et al., 2012; Meguid et al., 2008).  
5.2.3 Strengths and Limitations 
A major strength of this study is the large sample size provided by The Nevada Central Cancer 
Registry, enabling the creation of stable survival estimates by sex, race/ethnicity, stage of 
diagnosis, and region of Nevada for comparison purposes. Matching vital status with the NDI to 
completely capture deaths, customarily done in some other states, enhanced the accuracy of our 
survival estimates (Johnson et al., 2013).  
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Nonetheless, this study is subject to a few limitations. Incompleteness of the data for key 
prognostic variables, such as stage at diagnosis and CRC sublocation could have influenced the 
results of this study (Bray & Parkin, 2009; Parkin & Bray, 2009). Additionally, the quality of 
treatment data, especially receipt of chemotherapy and radiation, in cancer registries has not been 
thoroughly assessed across the United States (Cress et al., 2003; Smith-Gagen, Cress, Drake, 
Felter, & Beaumont, 2005). In the current study, incompleteness of treatment variables precluded 
assessment of receipt of TAG for many patients. Individual level data was not available for SES; 
our measure by zip code is subject to some degree of ecological fallacy. Registry data does not 
include comorbidities, an important determinant of CRC survival; research has shown that 
patients with many comorbidities have worse outcomes (Edwards et al., 2014; Gross et al., 
2006). However, our use of cause-specific survival partially compensates for the lack of 
comorbidity information. Additionally, we were unable to examine tumor markers and/or 
molecular subtypes that also negatively influence survival (Phipps et al., 2015). Individual-level 
CRC screening data is not available from registries; we used BRFSS estimates of CRC screening 
by geographical area. Lastly, in US cancer registries, foreign-born populations have more missed 
deaths, especially in a state like Nevada that uses the “presumed alive” method for censoring 
(Pinheiro, Morris, Liu, Bungum, & Altekruse, 2014). Thus, the survival for groups comprised of 
many immigrants, including Filipinos, Hispanics, and Other APIs, may be overestimated.   
5.2.4 Conclusions 
In conclusion, this study accurately characterized for the first time the colorectal cancer 
survival profile in the Mountain West state of Nevada, revealing disproportionately poor survival 
compared to the US. We further identified demographic, social, and clinical factors associated 
with CRC survival. The identification of these determinants should help cancer prevention and 
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control efforts, whether by seeking to intervene on modifiable determinants or providing 
programming to specific population groups. Certainly, CRC screening outreach efforts must 
continue and expand. A significant disparity between regions of Nevada was identified, 
disproportionately impacting rural and Southern Nevada, likely linked to access to care. Further 
studies are warranted in order to determine the barriers to receipt of TAG for colorectal cancer 
patients in Nevada. Collaboratively, all stakeholders, including clinicians and researchers, must 
aggressively approach any opportunities not only for primary prevention of colorectal cancer, but 
also to maximize the survival potential, at least reaching national levels, for all patients who are 
diagnosed with colorectal cancer in Nevada. Certainly, Nevada should not have outcomes so 
vastly disparate from the rest of the US states.   
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Chapter 6. Conclusions and Implications for Public Health 
 
One of the key goals of public health is to promote health equity, enabling all populations to 
achieve their maximum potential health, minimizing avoidable disparities. Yet, cancer research 
has consistently documented disparities among certain groups of people who have systematically 
experienced greater obstacles to health based on race/ethnicity, sex, geography, or other 
characteristics. Descriptive epidemiology has a unique role to play in identifying and 
characterizing these disparities. For CRC, population-level cancer disparities manifest 
themselves in lower than expected survival from a cancer diagnosis, as well as higher than 
expected incidence and mortality. In this dissertation, all CRC cases in Nevada were examined 
and direct evidence of CRC survival disparities by geographic region was found. In Nevada, 
patients from Clark County had significantly worse CRC survival than their counterparts in 
Northwestern Nevada, which is likely due at least partially to the fact that they did not receive 
treatment according to guidelines. Efforts to provide the best medical care, services, and 
treatment options to all CRC patients in Nevada must be ongoing to eliminate these striking 
geographic disparities.  
 In the second study, all CRC deaths in California were examined and direct evidence of 
mortality disparities by educational level were found, although the magnitude and direction of 
these disparities varied by race/ethnicity. Considering the interplay between survival and 
incidence as they ultimately express a mortality pattern, our findings are suggestive of a higher 
CRC incidence burden for higher-educated immigrants, and potential survival disparities for 
lower-educated immigrants. Thus, “one-size-fits-all” approaches to minimize disparities in CRC 
outcomes will have limited effectiveness. Ultimately, public health programs as well as policy 
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approaches to population-level disparities must be based on current and group-specific evidence, 
such as that provided here. To advance our nation towards healthy equity, programs must be 
tailored to distinct groups, including specificity by race/ethnicity, culture, birthplace, and 
educational level, among other factors. Clearly, increasing CRC screening is a critical step, as 
well as ensuring access to timely and appropriate treatment options for all, regardless of 
educational level, insurance status, geography, race/ethnicity, or other factors linked to 
disparities. Many deaths from CRC could be avoided if all Americans had incidence as low as 
the lowest groups, and survival as high as the highest surviving groups. Closing these gaps is the 
challenge we must be ready to face.    
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